GREGORY Y. LAUWERS, M.D.
(Curriculum Vitae prepared on May 11, 2009)
Office Address: Department of Pathology
Massachusetts General Hospital
55 Fruit Street, Warren 206
Boston, MA 02114-2696, USA
Phone: (617) 724-0961
Email: glauwers@partners.org
Fax: (617) 726-0982
Place of Birth: Paris, France
Education
1977 B.S., Physics and Biology Lycée Charlemagne, Paris, France
1980 Certificate of English as a Harvard Summer School, Cambridge, MA
Second Language
1986 Medical Doctor University of Paris VII, France
[presentation of thesis] C.H.U. Lariboisière - Saint Louis
Postdoctoral Training
1983-1985 Resident in Gastroenterology Meaux Hospital, University of Paris, France
1987-1990 Resident in Surgical Pathology Lenox Hill Hospital, New York, NY
(Chief Resident, 1989-1990)
1990-1992 Fellow in Oncologic Pathology Memorial Sloan-Kettering Cancer Center
(Chief Fellow, 1991-1992) New York, NY
Licensure and Certification
1992 American Board of Pathology: Anatomic Pathology
1993 Florida Licensure (inactive)
2000 Massachusetts Licensure
Academic Appointments
1992-1993 Instructor Department of Pathology, Memorial Sloan-Kettering
Cancer Center
1993-1998 Assistant Professor Division of Anatomic Pathology, Department of
Pathology, University of Florida
1996-1998 Joint Assistant Professor Division of Gastroenterology, Department of
Medicine, University of Florida
1998-2000 Associate Professor Division of Anatomic Pathology, Department of
Pathology, University of Florida
1998-2000 Joint Associate Professor Division of Gastroenterology, Department of
Medicine, University of Florida
2000‑ Associate Professor of Pathology Department of Pathology, Harvard Medical School
2005‑ Adjunct Professor of Pathology Saitama Medical School, Saitama, Japan
Hospital Appointments
1993-2000 Attending Pathologist Shands Hospital at the University of Florida
1993-2000 Consultant Pathologist Gainesville VA Medical Center, Gainesville, FL
1994-2000 Consultant Pathologist Shands Hospital at AGH
2000‑ Associate Pathologist Massachusetts General Hospital, Boston, MA
2000‑ Director Gastrointestinal Pathology Service
Massachusetts General Hospital, Boston, MA
2004‑ Associate Member Dana-Farber Cancer Institute, Boston, MA
Other Professional Positions
1992-1997 Consultant Pathologist IMPATH Laboratories Inc., Biotech Division
1993-2000 Consultant Pathologist Gainesville VA Medical Center, Gainesville, FL
1994-2000 Consultant Pathologist Shands at Alachua General Hospital, Gainesville, FL
Hospital Service Responsibilities
1996-1998 Coordinator Anatomic Pathology Operations Group
Shands Health System
1996-2000 Director Gastrointestinal and ENT Pathology Unit
Department of Pathology, Division of
Surgical Pathology, University of Florida
1997-2000 Associate Medical Director Histology Services, Shands Laboratories
Shands Hospital at the University of Florida
1998-2000 Director Division of Surgical Pathology
Department of Pathology, University of Florida
1999-2003 Director Gastrointestinal Pathology Fellowship
Department of Pathology, University of Florida
2000‑2006 Co-Director Massachusetts General Hospital Tumor Bank
2006-2008 Co-Director Division of Surgical Pathology
Department of Pathology
Massachusetts General Hospital, Boston
2001‑ Director GI Pathology Fellowship, Department of Pathology
Massachusetts General Hospital, Boston
2006‑ Director Massachusetts General Hospital Tumor Registry
2008‑ Director Division of Surgical Pathology
Department of Pathology
Massachusetts General Hospital, Boston
Major Committee Assignments
Local
1993-1995 Executive Planning Committee Member Cancer Center, University of Florida
1994-1997 Advisory Committee Member Tissue Resource Center
University of Florida
1994-1998 Surgical Case Review Committee Member Shands Hospital at the
University of Florida
1994-2000 Cancer Committee Member Shands Hospital at the
University of Florida
1994-1995 Operations Committees Member Department of Pathology
Diagnostic Referral Laboratories University of Florida
1994-1995 Executive Committee Member Department of Pathology
Diagnostic Referral Laboratories University of Florida
1996-1997 Surgical/Cytopathology Member Department of Pathology
Fellowship Committee University of Florida
1996-1998 Operating Room Committee Member Shands Hospital at the
University of Florida
1998-2000 Executive Committee Member Department of Pathology
University of Florida
2001‑ Clinical/Tissue Core, Center Co-Director Massachusetts General Hospital
for the Study of Inflammatory
Bowel Disease
2003‑ Quality Assurance Committee Member Department of Pathology, Massachusetts
General Hospital
National
1998-2000 Educational Committee Member Gastrointestinal Pathology Society
(Companion Society of USCAP)
1999- Present Pathology Committee Member American College of Radiology
Imaging Network
1999-2003 Commission on Cancer Member Study of Gastric Cancer Patient Care
Evaluation, American College of Surgeons
2000-2003 Educational Committee Chairperson Gastrointestinal Pathology Society
2001-2002 AJCC Staging Committee Member Digestive Cancers Task Force, AJCC Cancer
Staging Manual 2001-2002, 6th Ed.
2002-2004 Abstracts Review Board Member United States and Canadian Academy
GI Pathology of Pathology
2003-2005 Vice-president Gastrointestinal Pathology Society
2004-2005 President-elect Gastrointestinal Pathology Society
2005-2006 President Gastrointestinal Pathology Society
2007-2008 AJCC Staging Committee Member Digestive Cancers Task Force, AJCC Cancer
Staging Manual 2007-2008, 7th Ed.
2008-2010 Award Committee Member Benjamin Castleman Award, United States
And Canadian Academy of Pathology
Professional Societies
1987‑ U.S. and Canadian Academy of Pathology Member
1991‑ Gastrointestinal Pathology Society Member
1993-2000 Alachua County Medical Society Member
1995‑ International Gastric Cancer Association Member
1997‑ American Gastroenterological Association Member
1998‑ GI Pathology Study Group Member
2000‑ American Association for the Study of Liver Diseases Member
2003-2004 Gastrointestinal Pathology Society Vice-president
2004-2005 Gastrointestinal Pathology Society President-elect
2005-2006 Gastrointestinal Pathology Society President
Editorial Boards
1993- ad hoc reviewer Cancer
1994-1997 Coordinating Editor University of Florida GI Cancer Letter
1995- ad hoc reviewer International Journal of Cancer
1995- ad hoc reviewer American Journal of Gastroenterology
1997- ad hoc reviewer Gastrointestinal Endoscopy
1998- ad hoc reviewer The American Journal of Pathology
1998- ad hoc reviewer British Journal of Cancer
1999- ad hoc reviewer Gastroenterology
2001- ad hoc reviewer European Journal of Gastroenterology & Hepatology
2001- Editorial Board American Journal of Clinical Pathology
2002- ad hoc reviewer Surgery
2002- ad hoc reviewer Journal of Hepatology
2003- ad hoc reviewer Modern Pathology
2005-2006 Associate Editor Archives of Pathology and Laboratory Medicine
2005- ad hoc reviewer American Journal of Surgical Pathology
2006- Deputy Editor in Chief Archives of Pathology and Laboratory Medicine
2006- Editorial Board American Journal of Surgical Pathology
2007- Editorial Board Modern Pathology
Awards and Honors
1985 Rotary Foundation Award for International Understanding
1997-1998 Residents’ Faculty Recognition Award for Outstanding Contributions to the
Residency Program, University of Florida
2007-2010 Benjamin Castleman Award Committee
United States and Canadian Academy of Pathology
Part II: Research, Teaching, and Clinical Contributions
A. Narrative Report
I am a full-time gastrointestinal and hepatopancreaticobiliary pathologist at the MGH. My research focuses on Barrett’s esophagus-related neoplasms and gastric neoplasia, with an emphasis on precursor lesions and early cancer. After authoring several articles on diagnostic and biologic aspects of dysplastic lesions of the upper gastrointestinal tract, I pioneered a field of study focusing on the pathologic assessment of new diagnostic and therapeutic modalities, i.e., photodynamic therapy (PDT) and endoscopic mucosal resection (EMR). My group was the first to recognize the importance of several features predicting response to PDT, and ongoing work is investigating differences in molecular alterations (aneuploidy, COX-2 expression) in an attempt to understand the variable response to treatment. We were also the first to complete several studies on the diagnostic and staging utility of EMR and to present guidelines for its evaluation. I also have been collaborating on evaluating the diagnostic capabilities of optical coherent tomography (OCT) in the screening and surveillance in patients with Barrett’s esophagus. In recognition of my expertise in the field, I have been asked to edit the next AFIP Fascicle on Tumors of the Esophagus and Stomach, to be published in 2009.
A secondary major research interest is pancreatic neoplasia and its mimics, notably autoimmune pancreatitis. With regard to autoimmune pancreatitis, my group published the first comprehensive analysis of the fine needle aspiration biopsy features of this entity and also has investigated the role of IgG4 in this disease. Notably, we have characterized the multicentric nature of this disease and are interrogating the role of T-cells in this inflammatory pathology. We were also the first group to show that the expression of keratin 19, a marker of ductal phenotype, is a powerful predictor of malignancy in pancreatic endocrine tumors. To date, our finding has been confirmed by five independent international studies and is rapidly being accepted as a new diagnostic marker. Finally, using well-characterized cohorts of pancreatic mucinous cystic neoplasms, we are currently developing definitive guidelines for the cytopathologic evaluation of these neoplasms. As recognition of my expertise in the field, I was asked to participate to the 2002 and 2007 American Joint Committee on Cancer hepatopancreaticobiliary working groups.
I am extensively involved in the education of pathology residents, GI pathology fellows, and clinical gastroenterology fellows at Massachusetts General Hospital. Since 2002, I have created and directed the MGH Gastrointestinal Pathology Fellowship. This one-year program provides in-depth diagnostic and clinical research expertise in gastrointestinal and hepatopancreaticobiliary pathology. Currently, all our graduates are in academic practice all over the country. I have also mentored several international trainees who now hold academic positions worldwide. In addition, I serve as the director of Surgical Pathology Fellowship for the MGH. At the postgraduate level, I co-direct the “Gastrointestinal, Liver, and Pancreatic Pathology” course given each year in Boston. Finally, I am an Adjunct Professor of Pathology at Saitama Medical University, Japan, where I teach second-year medical students every year. I have given lectures nationally and internationally on various aspects of gastrointestinal pathology, and have organized and co-directed two international courses on GI pathology. I have served on program and abstract committees for a number of national and international pathology meetings, am on the editorial boards of four leading clinical pathology journals, and serve as an Associate Editor-in-Chief of the Archives of Pathology and Laboratory Medicine.
My clinical work centers on gastrointestinal pathology, including directing the gastrointestinal pathology service at the MGH and GI pathology consult cases from pathologists around North America and overseas. My administrative duties involve the directorship of the Gastrointestinal Pathology Service. I have forged a strong diagnostic group, now one of the best in the nation. I am proud of the scientific mentorship provided to my younger colleagues, two of whom have recently been promoted at HMS and are emerging as national figures in the field of gastrointestinal pathology. I also have been instrumental in fostering strong collaborative clinical, investigational, and educational efforts with the Divisions of Gastroenterology and General Surgery. Since October of 2006, I have also been Co-Director of Surgical Pathology, the largest faculty division of the Pathology Service at MGH. I have enabled a number of significant changes in this division, using new information systems and laboratory technology while enhancing patient safety, staff satisfaction and quality of clinical and translational research. Finally, I also direct the MGH Tissue Repository (”tumor bank”), which provides tissue throughout the Partners system and beyond. Under my leadership, the bank has been able to offer new services and to recruit several previously independent banks into our standardized, IRB-approved system, which has directly benefited the MGH scientific community.
B. Funding Information
Educational
1994 University of Florida PI Development of UF GI cancer letter
Cancer Center
1995 University of Florida PI Development of UF GI cancer letter
Cancer Center
Research
1995 University of Florida Department PI Biologic dissection of dysplasia in
of Sponsored Research stomach and Barrett’s esophagus
2000-2005 NIH-DHHS co-investigator Center for the Study of
Inflammatory Bowel Disease (CSIBD)
5P30-DK4331-13
2003-2005 NIH co-investigator Angiogenic Profile of Rectal Cancer
R21CA099237
2003-2008 NIH co-investigator Improving Screening and Surveillance
in Barrett’s Patients
R01 CA 103769
2004-2009 NIH co-investigator Molecular Epidemiology of
Esophageal Cancer Prognosis
R01 CA109193-01
2006-2008 NIH/NCI co-investigator Phase I Clinical Trial of Viral
Oncolysis of Liver Tumors
R21 CA119600-01
2006-2010 NIH/NIDDK co-investigator Center for Studies in Inflammatory
Bowel Disease - Core B - Clinical
Tissue Core
SP30 DK043351-18
Clinical
1997 Schering-Plough co-PI Intron A (interferon β-2b) plus ribavirin
versus placebo in early post-transplantation treatment in patients transplanted for hepatitis C liver disease
2006‑2008 Almac Diagnostics co-investigator Clinical Cancer Biomarker
Discovery
C. Report of Current Research Activities
Study of gastric gland neck dysplasia: Morphometric analysis PI
Hepatic preneoplastic lesions: Development of accurate diagnostic criterion co-PI
Evaluation of endoscopic mucosal resection as a diagnostic and staging tool PI
Evaluation of resistance to PDT in the treatment of esophageal high grade dysplasia PI
D. Report of Teaching
Local Contributions
University of Florida Medical School
1993-1999
Second year medical students
Course #5600, fall semester: Systemic pathology, GI pathology section
Lecturer (full class presentation)
4 one-hour lectures and 6 one-hour laboratories, for a total of 10 hours of teaching per academic year;
4 hours of preparation per year
1993-2000
Pathology residents
Series of didactic lectures covering crucial aspects of GI pathology and given over a two-year schedule
6 hours of lectures per year; 6 hours per year preparation time
1993-2000
Pathology residents
Slide seminars at the multiheaded microscope with review of challenging gastrointestinal cases
1 hour per week, about 30 hours per year; no preparation
1993-2000
Clinical GI Fellows
Series of didactic lectures covering crucial aspects of gastrointestinal pathology to improve the understanding of microscopic pathology and to be given over a two-year schedule
4 hours of lectures per year; 4 hours per year preparation time
University of Florida Dental School
1997-2000
Course #6153, spring semester: Systemic pathology, GI pathology section
Second year dental students
Lecturer (full class presentation)
3 one-hour lectures per year; 3 hours per year preparation time
Harvard Medical School
2002‑
HMS II, Human Systems Course: Lower gastrointestinal pathology
Second year medical students
Lecturer, approximately 35 students
1 two-hour lecture per year; 4 hours per year preparation time
Local Invited Teaching Presentations
“Gastric carcinogenic sequence: an immunohistochemical analysis.” University of Florida, Department of Pathology and Laboratory Medicine Faculty Seminar; Gainesville, FL, April 18, 1994.
“Gastritis: a practical and updated review.” Florida West Coast Association of Pathologists, Tampa, FL, November 16, 1995.
“Cellular kinetics in Barrett’s epithelium carcinogenic sequence: roles of apoptosis, bcl-2 protein, and cellular proliferation.” Research Seminar, Division of Nephrology, Hypertension and Transplantation, University of Florida, College of Medicine, Gainesville, FL, February 12, 1998.
“Familial adenomatous polyposis.” University of Florida, Department of Surgery, Grand Rounds, Gainesville, FL, February 2, 2000.
“Gastric dysplasia: Current understanding, limitations and future directions.” Massachusetts General Hospital, Division of Gastroenterology Grand Rounds, Boston MA, November 14,2000.
“Hepatocellular Carcinoma.” Brigham and Women’s Hospital Pathology Department Grand Rounds. October 26, 2001.
Liver Pathology - AP/CP correlation. The Massachusetts Society of Pathologists. CME program. Newton, MA, November 2, 2000.
“Hepatocellular Carcinoma: Diagnosis and Prognosis.” Beth Israel Hospital - Pathology Department Grand Rounds. January 13, 2003.
“Esophageal and Gastric Biopsy Interpretation” (Meet-the-Professor session). Harvard Medical School Comprehensive Review of Gastroenterology, Boston, MA. May 2, 2003.
“HCC: Diagnosis and Prognosis.” MGH Division of Gastroenterology, Grand Rounds. July 29, 2003.
“Autoimmune pancreatitis: an update.” Department of Pathology, Brigham and Women’s Hospital. Surgical Pathology Update Series Boston, MA. January 5, 2007.
Continuing Medical Education Courses
“Dysplasia in inflammatory bowel disease, a major diagnostic challenge,” 5th Course, Inflammatory Bowel Disease: Experience and Controversy. Lenox Hill Hospital New York, NY, April 6‑7, 1990
“Gastrointestinal autonomic nerve tumor,” Anatomic Pathology Slide Seminar, XVI Annual Memorial Hospital Alumni Society Meeting, New York, NY, November 22, 1991.
“Surgical Pathology of Neoplastic Diseases.” Memorial Sloan-Kettering Cancer Center New York, NY, 1992.
“Rare lesions of the gastrointestinal tract,” Surgical Pathology of Neoplastic Diseases Course. Memorial Sloan‑Kettering Cancer Center, New York, NY, May 4‑8, 1992.
“Duodenal gangliocytic paraganglioma,” Anatomic Pathology Slide Seminar, XVII Annual Memorial Hospital Alumni Society Meeting, New York, NY, November 6, 1992.
Surgical Pathology of Neoplastic Diseases. Memorial Sloan-Kettering Cancer Center New York, NY, 1993.
“Characterization of upper GI lesions,” Surgical Pathology of Neoplastic Diseases Course. Memorial Sloan‑Kettering Cancer Center, New York, NY, May 3‑7, 1993.
ASCP Workshop: “Gastric pathology: an updated review and practical approach to diagnosis,” Boston, MA, April 2, 1996 (with co-director Sheahan DG).
ASCP Workshop: “Gastric pathology: an updated review and practical approach to diagnosis”; second presentation, Philadelphia, PA. September 23, 1997 (with co-director Sheahan DG).
ASCP Workshop: “Gastric pathology: an updated review and practical approach to diagnosis”; third presentation, New Orleans, LA, September 29, 1999.
“Liver biopsy interpretation, emphasizing commonly encountered problems in daily practice.” Current Concepts in Surgical Pathology. 22nd Annual Course (MGH Course, Boston, MA, November 13, 2000).
“Colitis: An algorithmic approach emphasizing new entities.” Current concepts in Surgical Pathology. 22nd Annual Course (MGH Course, Boston, MA, November 14, 15 &17, 2000).
“Interpreting Esophageal and Gastric Biopsies.” Combined BWH, BID, & MGH Comprehensive Review of Gastroenterology Course, Boston, MA, 2001.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. 2001.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, 2001.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, 2001.
Solitary Liver Masses: Benign and Malignant. Current concepts in Surgical Pathology. 22nd Annual course (MGH Course, Boston, MA, November 13 & 16, 2001).
“Interpreting Esophageal and Gastric Biopsies.” Combined BWH, BID, & MGH Comprehensive Review of Gastroenterology. Course, Boston, MA, 2002.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. 2002.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, 2002.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, 2002.
“Gastric pathology: an updated review and practical approach to diagnosis,” ASCP Weekend of Pathology, fourth presentation, Santa Monica, CA, June 7, 2002.
“Solitary Liver Masses: Benign and Malignant.” Current Concepts in Surgical Pathology, 24th Annual Course. Harvard Medical School and MGH Course, Boston, MA, November 13, 2002.
“Colitides: an algorithmic approach to the diagnosis.” Current Concepts in Surgical Pathology, 24th Annual Course. Harvard Medical School and MGH Course, Boston, MA, November 15, 2002.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Chicago, IL, April 2003.
“Interpreting Esophageal and Gastric Biopsies.” Combined BWH, BID, & MGH Comprehensive Review of Gastroenterology. Course, Boston, MA, 2003.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. 2003.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, 2003.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, 2003.
“Colitis: An algorithmic approach emphasizing new entities.” Current Concepts in Surgical Pathology. 25th Annual Course (MGH Course, Boston, MA, November 10-14, 2003).
“Polypoid Lesions of the stomach.” Current Concepts in Surgical Pathology. 25th Annual course (MGH Course, Boston, MA, November 10-14, 2003).
“A Practical Approach to the Diagnosis of Colitis.” Current Concepts in Surgical Pathology. 25th Annual course (MGH Course, Boston, MA, November 10-14, 2003).
“Inflammatory Bowel Disease: Criteria for Diagnosis Including Dysplasia.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Ft. Myers, FL. March 27, 2004.
“Colitis Other Than Inflammatory Bowel Disease.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Ft. Myers, FL. March 27, 2004.
“Gastric Pathology Emphasizing Gastritis, Polyps, and Their Complications.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Ft. Myers, FL. March 28, 2004.
“The Solitary Liver Mass: Problems in Interpretation.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Ft. Myers, FL. March 28, 2004.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Santa Fe, NM, April 19, 2004.
“Interpreting Esophageal and Gastric Biopsies.” Combined BWH, BID, & MGH Comprehensive Review of Gastroenterology Course, Boston, MA, April 30, 2004.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. May 10, 2004.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 11, 2004.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 11, 2004.
“Polyps, cancer arising in them, and nomenclature of colorectal neoplasia.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Scottsdale, AZ, January 16-17, 2005.
“Gastric pathology emphasizing gastritis, polyps and their complications.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Scottsdale, AZ, January 16-17, 2005.
“Inflammatory bowel disease: criteria for diagnosis including dysplasia.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Scottsdale, AZ, January 16-17, 2005.
“Assessment of the solitary liver mass.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Scottsdale, AZ, January 16-17, 2005.
“Colitis other than inflammatory bowel disease.” MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. Scottsdale, AZ, January 16-17, 2005.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. May 2005.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2005.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 2005.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Rancho Mirage, CA, April 2005.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. May 2006.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2006.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 2006.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Charleston, SC, May 2006.
“A practical approach to the cytopathology and surgical pathology of cystic pancreatic lesions.” Weekend of Pathology. American Society for Clinical Pathology. Las Vegas, NV, February 10, 2007.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. May 2007.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2007.
“Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 2007.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Phoenix, AZ, May, 2007.
“Gastric Pathology: an updated review and practical approach.” American Society for Clinical Pathology, Miami, FL, April 26, 2008.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA. May 2008.
“Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2008.
“Non-IBD colitis.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2008.
“Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Santa Barbara, CA, June, 2008.
“Inflammatory Bowel Disease: Histologic Controversies and Solutions.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March, 2009.
“Other Forms of Colitis: Survey of Their Broad Spectrum.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March, 2009.
“Gastritis and Gastropathies, Other than H. Pylori Gastritis.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March, 2009.
“Gastric Tumors: An Update.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March, 2009.
“Biopsy diagnosis of inflammatory diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
“Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
“Non-IBD colitis.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
“Gastrointestinal manifestations of systemic disorders.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
“Update on colon cancer.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
“Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 2009.
International Trainees
January-July 1995 O. Kandemir, M.D. Erciyes University, Kayseri, Turkey
October 1999-January 2000 Y.F. Lo, M.D. Caritas Medical Centre, Hong Kong
October 1999-January 2000 K. Kanehira, M.D. Kyoto University, Kyoto, Japan
July-September 2001 C. Richards, MRCPath Univ. Hospitals of Leicester University, U.K.
May-June 2002 I. Michaelides, M.D. Nicosia General Hospital, Nicosia, Cyprus
July 2002-July 2003 S. Ban, M.D. Saitama Medical School, Saitama, Japan
January 2003-March 2004 S. Tomita M.D. Dokkyo U. School of Medicine, Tochigi, Japan
October 2004-March 2005 M. Ohana, M.D. Kyoto University, Kyoto, Japan
July 2005-June 2007 D.-Y. Park, M.D., Ph.D Pusan University, Pusan, South Korea
September-December 2007 E. Gonzalez Obeso, M.D., Ph.D. Hospital Universitario La Paz, Spain
October 2007-Nov. 2008 F. Ogawa, M.D. Saitama Medical University, Saitama, Japan
September-November 2008 M. Genevay, M.D. Université de Genève, Geneva, Switzerland
GI Pathology Fellows
July 2001-June 2002 Massimo d’Apuzzo, M.D. Stanford University, Palo Alto, CA
July 2002-June 2003 Mari Mino, M.D. Massachusetts General Hospital, Boston
July 2005-June 2006 Amitabh Srivastava, M.D. Dartmouth-Hitchcock Medical Center,
Lebanon, NH
July 2006-June 2007 Alireza Sepehr, M.D. Beth Israel Deaconess Medical Center, Boston
July 2007-June 2008 Jey-Hsin Chen, M.D. Indiana University, Indianapolis, Indiana
July 2008-June 2009 Mikhail Lisovsky, M.D. Dartmouth-Hitchcock Medical Center,
Lebanon, NH
2. Regional, National and International Invited Presentations
Regional
“When it is neither ulcerative colitis nor Crohn’s disease, what can it be? A practical differential diagnosis of colitides.” Florida Society of Pathologists, 25th Annual Anatomic Pathology Conference, Orlando, FL, January 28-31, 1999.
“Diagnostic challenges in medical liver pathology: a review of the most commonly referred cases.” Florida Society of Pathologists, 25th Annual Anatomic Pathology Conference, Orlando, FL, January 28-31, 1999.
“From H. pylori gastritis to gastric cancer: the role of surgical pathologists.” Update in Diagnostic Pathology and Medicine Series. Baystate Medical Center, Springfield, MA. April 9, 2003.
“Inflammatory Bowel Disease: Current Diagnostic Issues Including Assessment and Management of Pre-neoplastic Lesions” Massachusetts Society of Pathologists. Massachusetts Medical Society, Waltham, MA. October 26, 2005.
“Autoimmune Pancreatitis.” GI Grand Rounds, Core Curriculum Conference, Massachusetts General Hospital, March 6, 2007
National
“Unusual tumors of the gastrointestinal tract,” University of California at San Diego, San Diego, CA, December 1, 1992.
“Rare tumors of the gastrointestinal tract,” Presbyterian University Hospital, Pittsburgh, PA, December 15, 1992.
“Role of bcl-2 protein in gastric carcinogenesis,” Institute of Pathology, Shadyside Hospital, Pittsburgh, PA, October 24, 1995.
“Gastric dysplasia: Diagnostic discrepancies when East meets West,” Gastrointestinal Pathology Society Companion Meeting. 99th Annual Meeting of American Gastroenterological Association, New Orleans, LA, May 19, 1998.
“Gastric neoplasms and Helicobacter pylori: What’s the connection?” Invited lecture. Lenox Hill Hospital, New York, NY, October 29, 1998.
“Gastric dysplasia: Current understanding, limitations and future directions” Pathology Grand Rounds. M.D. Anderson Cancer Center, Houston, TX, December 18, 1998.
“Challenges and future directions of gastric epithelial dysplasia.” Department of Pathology, Johns Hopkins University, Baltimore, MD, February 9, 1999.
“Gastric dysplasia: Current understanding, limitations and future directions.” Massachusetts General Hospital, Boston, MA, January 27, 2000.
“Duodenal gangliocytic paraganglioma.” United States and Canadian Academy of Pathology Gastrointestinal Pathology Evening Specialty Conference. New Orleans, LA, March 30, 2000.
“Gastric Dysplasia: Diagnosis, significance and Controversies.” Gastrointestinal Pathology Society Companion Meeting at the ASCP. San Diego, CA October 13, 2000
“Focal active colitis associated with NaP bowel preparation” United States and Canadian Academy of Pathology/Gastrointestinal Pathology Evening Specialty Conference. Atlanta, GA, March 7, 2001.
“Neoplastic Pathology of the Vermiform Appendix.” Gastrointestinal Pathology Society Companion Meeting at the ASCP. Philadelphia, PA, October 19,2001.
“Paraneoplastic Chronic Intestinal Pseudo-obstruction.” United States and Canadian Academy of Pathology/Gastrointestinal Pathology Evening Specialty Conference. New Orleans, LA, February 26, 2002.
“Defining the Pathologic diagnosis of gastric metaplasia, atrophy, dysplasia, and adenocarcinoma” Yale University School of Medicine/ Norwalk Hospital. Gastrointestinal Cancer Prevention. Friday, October 4, 2002. Norwalk, CT
Pathology of Autoimmune Pancreatitis. Pancreas Club (Digestive Disease Week). Oshner Clinic. New Orleans, LA. May 16, 2004.
“Management of early neoplasms in Barrett’s Esophagus: pathologists’ experience with novel endoscopic techniques.” Gastrointestinal Pathology Society Companion Meeting at the ASCP Annual Meeting. Seattle, WA October 7, 2005.
“Autoimmune pancreatitis: an evolving condition.” Duke University School of Medicine, Durham, NC. March 8, 2007.
“Modern endoluminal therapeutic modalities: the pathologist’s perspective” Update on Esophageal Diseases. Rodger C. Haggitt Gastrointestinal Pathology Society Annual Companion meeting. United States and Canadian Academy of Pathology Annual Meeting. San Diego, CA, March 2007.
“Gastritis when it is not Helicobacter pylori related.” Pathology Grand Rounds. Methodist Hospital, Houston, April 2007.
“Colitis Other than IBD: Selected Issues.” Houston Society of Clinical Pathologists. 47th Annual Spring Symposium Gastrointestinal Pathology Update. April 12, 2007.
“Autoimmune pancreatitis: a disorder extending its scope.” Visiting professorship, The University of Illinois at Chicago College of Medicine. October 15, 2007.
“Early Barrett’s esophagus neoplasms: a pathologist’s experience with novel endoscopic techniques.” Grand Rounds, Memorial Sloan-Kettering Medical Center. November 8, 2007.
“Early Barrett epithelium neoplasm: a pathologist’s experience with novel endoscopic techniques.” Pathology Research and Review Seminar, Dartmouth Medical School, December 11, 2007. (Visiting Professor)
“Pathology of Early Gastric Neoplasms - Evolving Concepts and Clinical Implications.” GI Cancer Program Research Seminar Series, M.D. Anderson Cancer Center, January 8, 2008. (Visiting Professor)
International
Co-Chairperson, “C-MET” Session at 1st International Gastric Cancer Congress, March 29 - April 1, 1995; Kyoto, Japan.
“Helicobacter Pylori - An Update,” Himeji National Hospital, April 3, 1995; Himeji, Japan.
“Bcl-2 protein expression in gastric carcinogenesis. An immunohistochemical study,” Kyoto University Surgical Seminar, April 4, 1995; Kyoto, Japan.
“Role of Helicobacter pylori in the genesis of gastric neoplasia-current concepts,” Kyoto University Surgical Seminars, May 27, 1997; Kyoto, Japan.
“Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. Hepatocellular carcinoma in the Eastern and Western experiences.” August 28-29, 1998; Paris, France.
“Bile ducts alterations in the setting of OLT,” slide seminar. Department of Pathology, Kyoto University, June 8, 1999; Kyoto, Japan.
“Gastric dysplasia: current understanding and future directions.” Kyoto University Surgical Seminars, June 8, 1999; Kyoto, Japan.
“Hepatocellular carcinoma - evaluation of clinicopathologic features from three distinct geographic areas,” 35th Annual Meeting of Liver Cancer Study Group of Japan. Kyoto, Japan, June 10, 1999.
“Pathology of Biliary Cancer: Current Knowledge and Challenges.” Annual Meeting of the European Organization for Research and Treatment of Cancer. EORTC Educational Session on Diagnostic and Therapeutic Aspects of Biliary Cancer. Hospital Fernando Fonseca, Lisbon Portugal, October 20,2001.
“Hepatocellular Carcinoma - Pathological indicators of prognosis” Falk Workshop on Malignant Liver Tumors: Basic Concepts and Clinical Management. Leipzig (Germany) January 24-25, 2002.
“The Diagnosis of Colitis-A Stepwise Approach.” Saitama Medical School Post Graduate Educational Program. Saitama Medical School, Moroyama, Japan, November 17, 2003.
“Barrett’s Esophagus: Persistent Issues and New Challenges.” Japanese Society of Pathology. Sapporo, Japan. June 11, 2004.
“Colonic Polyps: Criteria for complete excision and pseudoinvasion.” Australian Gastroenterological Week of the Gastroenterological Society of Australia (GESA). Brisbane, Australia, October 8, 2004.
“Iatrogenic Pathology of the Stomach.” University of Geneva, Switzerland. November 15, 2004.
“Early neoplasms in Barrett’s esophagus: pathologists’ experience with new interventional endoscopic techniques.” The Fourth Asia-Pacific IAP Congress. Beijing, People’s Republic of China, August 26, 2005.
“Gastric Polyps and dysplasia.” Gastrointestinal Pathology Course organized by the Hospital del Mar and Autonomous University of Barcelona, School of Medicine. Barcelona, Spain. January 18-20, 2006.
“Non-Helicobacter pylori gastritis: What else?” Gastrointestinal Pathology Course organized by the Hospital del Mar and Autonomous University of Barcelona, School of Medicine. Barcelona, Spain. January 18-20, 2006.
“Diagnosis and differential diagnosis of cystic pancreatic tumors.” Gastrointestinal Pathology Course organized by the Hospital del Mar and Autonomous University of Barcelona, School of Medicine. Barcelona, Spain. January 18-20, 2006.
“Early Neoplasms in Barrett’s Esophagus: Pathologists’ Experience with Novel Endoscopic Techniques.” Catalan Society of Pathology, Barcelona, Spain, January 19, 2006.
“Prognostic Factors of Colorectal Cancer” in Practical Approach in Gastrointestinal Pathology organized by the Spanish Society of Anatomic Pathology. Madrid, Spain, May 26, 2006.
“Pancreatic Cystic Neoplasms” in Practical Approach in Gastrointestinal Pathology organized by the Spanish Society of Anatomic Pathology. Madrid, Spain, May 26, 2006.
“Hepatocellular Carcinoma -Morphology, Differential Diagnosis and Prognostic Factors” in Practical Approach in Gastrointestinal Pathology organized by the Spanish Society of Anatomic Pathology. Madrid, Spain, May 26, 2006.
“Inflammatory Bowel Disease: Diagnostic Problems Including Dysplasia” Diagnostic Surgical Pathology 2006. Florence, Italy. June 8, 2006.
“Gastric Polyps: Classification, Significance and Management Implications” Diagnostic Surgical Pathology 2006. Florence, Italy. June 8, 2006.
“Colitis Other Than Inflammatory Bowel Disease: Selected Issues” Diagnostic Surgical Pathology 2006. Florence, Italy. June 8, 2006.
“Steatosis and Steatohepatitis: Definition of Standard Criteria.” Hot-Topic “Chemotherapy-Associated Hepatotoxicity in the Treatment of Hepatic Colorectal Metastases.” Institut de Cancerologie Gustave Roussy International Scientific Symposium. Villejuif, France, September 27,2006.
“Gastritis when it is not Helicobacter pylori related.” Plenary lecture. 5th Asia Pacific International Academy of Pathology Congress. Singapore, May 2007.
“Gastric polyps: Diagnosis and therapeutic issues.” 5th Asia Pacific International Academy of Pathology Congress. Singapore, May 2007.
“Pancreatic cystic neoplasms: An update.” 5th Asia Pacific International Academy of Pathology Congress. Singapore, May 2007.
“What to expect from surgical pathology reports of colorectal cancer specimens: An update.” Insubria International Summer School. Varese, Italy, September 27, 2007.
“Early Barrett epithelium neoplasms: A pathologist’s experience with novel endoscopic techniques.” Saitama Medical University, Moroyama, Japan, November 26, 2007.
“Autoimmune pancreatitis: cytology and histology.” First Belgian Week of Pathology, Ghent, Belgium, March, 2008.
“Endoscopic mucosal resection” (keynote lecture). First Belgian Week of Pathology, Ghent, Belgium, March, 2008.
“Gastric dysplasia and gastric polyps.” XVII Porto Cancer Meeting on Pathology of the Digestive System, Institute of Pathology and Molecular Pathology of the University of Porto (IPATIMUP), Porto, Portugal, April 12, 2008.
“Pancreatic cystic tumors.” XVII Porto Cancer Meeting on Pathology of the Digestive System, Institute of Pathology and Molecular Pathology of the University of Porto (IPATIMUP), Porto, Portugal, April 12, 2008.
“Non-IBD Colitis.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 3, 2008.
“IBD Colitis.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 3, 2008.
“Hepatic Neoplasms.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 3, 2008.
“Autoimmune Pancreatitis.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 3, 2008.
“Gastric Dysplasia and Early Gastric Cancer.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 4, 2008.
“Non-HP Gastritis.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 5, 2008.
“Pancreatic Cystic Neoplasms.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 6, 2008.
“Barrett’s Oesophagus and Dysplasia.” University of Western Australia, PathWest Visiting Professor 2008, Perth, Australia, November 6, 2008.
“Gastritis Beyond H. pylori: Extending our Horizons.” Saitama Medical University, Moroyama, Japan, December 16, 2008.
“Cystic tumors of the pancreas.” XIVth Indo-US International CME in Surgical Pathology, Cytology, and Hematology, Agra, India, February 2009.
“Non-epithelial Tumors of the GI Tract.” XIVth Indo-US International CME in Surgical Pathology, Cytology, and Hematology, Agra, India, February 2009.
E. Report of Clinical Activities
Since July 2000, I have been Chief of the Gastrointestinal Pathology Service in the Department of Pathology at the MGH. This unit diagnoses about 14,000 cases per year. The clinical load encompasses the gamut of benign and oncologic material.
Part III: Bibliography
Original Articles
1. Korelitz B, Lauwers GY, Sommers S. Rectal mucosal dysplasia in Crohn’s disease. Gut. 1990; 31:1382-1386.
2. Frankel SR, Eardley A, Lauwers GY, Weiss M, Warrell RP. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med 1992; 117:292-296.
3. Lauwers GY, Schevchuk M, Armenakas N, Reuter V. Carcinosarcoma of the prostate. Am J Surg Pathol 1993; 17:342-349.
4. Lauwers GY, Melamed J, Rojas-Corona R. Blood group antigens in Barrett’s esophagus and associated adenocarcinomas. Mod Pathol 1993; 6:588-591.
5. Lauwers GY, Erlandson RA, Casper ES, Brennan MF, Woodruff JM. Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical and ultrastructural study of 12 cases. Am J Surg Pathol 1993;17:887-897.
6. Rao PH, Mathew S, Lauwers GY, Rodriguez E, Kelsen DP, Chaganti RSK. Interphase cytogenetics of gastric and esophageal adenocarcinomas. Diag Mod Pathol (Am J Surg Pathol, Part B). 1993; 2:264-268.
7. Lauwers GY, Wahl SJ, Melamed J, Rojas-Corona RR. p53 Expression in Precancerous Gastric Lesions. An immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 1993; 88:1916-1919.
8. Saltz L, Lauwers GY, Wiseberg J, Kelsen D. A Phase II Trial of Carboplatin in Patients with Advanced APUD Tumors. Cancer 1993; 72: 619-622.
9. Fortner J, Lauwers GY, Thaler H, Concepcion R, Friedlander-Klar M, Kher U, Maclean B. Nativity, Complications, Pathology are Determinants of Surgical Results for Gastric Cancer. Cancer 1994; 73:8-14.
10. Paty P, Enker W, Cohen A, Lauwers GY. Treatment of Rectal Cancer by Low Anterior Resection with Coloanal Anastomosis. Ann Surg 1994; 219:365-373.
11. Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994; 73 :2900-2904.
12. Minsky BD, Enker WE, Cohen AM, Lauwers GY. Local excision and postoperative radiation therapy for rectal cancer. Am J Clin Oncol 1994; 17:411-416.
13. Zhang ZF, Karpeh MS, Lauwers GY, Marrero AM, Pollack D, Cordon Cardo C. Risk Factors and p53 Nuclear Overexpression in Early Stage Intestinal-type Adenocarcinoma of the Stomach. J Cancer Detection Prev 1995; 19:156-164.
14. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical Evaluation of bcl-2 Protein Expression in Gastric Adenocarcinomas. Cancer 1995; 75:2209-2213.
15. Minsky BD, Enker WE, Cohen AM, Lauwers GY. Clinicopathologic Features in Rectal Cancer Treated by Local Excision and Postoperative Radiation Therapy. Radiation Med 1995; 13:235-241.
16. Lauwers GY, Wahl SJ, Scott GV, DeRoux SJ. Papillary mucinous adenoma arising in adenomatous hyperplasia of the gall bladder. J Clin Pathol 1995; 48:965-967.
17. Merchant TE, Diamantis PM, Lauwers GY, Haida T, Kasimos JN, Guillem J, Glonek T, Minsky BD. Characterization of malignant colon tumors with 31P NMR phospholipid and phosphatic metabolite profile. Cancer 1995; 76:1715-1723.
18. Zhang ZF, Karpeh MS, Lauwers GY, Marrero AM, Pollack D, Cordon Cardo C, Begg CB. A case-series study of p53 nuclear overexpression in early stage stomach cancer. Cancer Prevention/N. Y. Academy of Sciences 1995; 768:269-271.
19. Albino AP, Jaehne J, Altorki N, Blundell M, Urmacher C, Lauwers GY, Niedzwiecki D, Kelsen DP. Amplification of HER-2/new gene in human gastric adenocarcinomas correlation with primary site. Eur J Surg Oncol 1995; 21:56-60.
20. Marsh R de W, Chu N, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C, Copeland EM. Preoperative Treatment of Locally Advanced and Unresectable Rectal Adenocarcinoma Utilizing Continuous Chronobiologically Shaped 5-FU Infusion and Radiation Therapy. Cancer 1996; 78;217-25.
21. Saunders M, Meloni AM, Chen Z, Sandberg AA, Lauwers GY. Two cases of low grade gastric leiomyosarcoma with monosomy 14 as the only change. Cancer Genet Cytogenet 1996; 90:184-185.
22. Fujita S, Rosen CB, Reed AI, Langham Jr. MR, Howard RJ, Lauwers GY, Scornik JC. The Significance of Performed Anti-Donor Antibodies in Liver Transplantation. Transplantation 1997; 63:84-88.
23. Solorzano CC, Pruitt JH, Ksontini R, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Copeland III EM, Edwards CK, Lauwers GY, Clare-Salzler M, MacKay SLD, Moldawer LL, Lazarus DD. Involvement of 26kD Cell-Associated TNFa in Experimental Hepatitis and Exacerbation of Liver Injury with a TNFa Convertase Inhibitor. J Immunol 1997;158:414-19.
24. Vauthey JN, Tomczak RJ, Helmberger T, Gertsch P, Forsmark C, Caridi J, Reed A, Langham MR, Lauwers GY, Goffette P, Lerut J. The Arterioportal Fistula Syndrome: Clinico pathological Features, Diagnosis and Therapy. Gastroenterology 1997;113:1390-1401.
25. Lauwers GY, Kandemir O, Kubilis PS, Scott GV. Cellular Kinetics in Barrett’s Epithelium Carcinogenic Sequence: Roles of Apoptosis, Bcl-2 protein and cellular proliferation. Mod Pathol 1997; 12:1201-1208.
26. Lauwers GY, Grant LD, Scott GV, Carr NJ, Sobin LH. Spindle Cell Squamous Carcinoma of the Esophagus. Analysis of ploidy and tumor proliferative activity in a series of 13 cases. Hum Pathol 1998;29:863-868.
27. Lauwers GY, Shimizu M, Correa P, Riddell RH, Kato Y, et al. Evaluation of Gastric Biopsies for Neoplasia: Differences Between Japanese and Western Pathologists. Am J Surg Pathol 1999;23:511-518.
28. Dickson RC, Lauwers GY, Rosen CB, Cantwell R, Nelson DR, Lau, JYN. The Utility of Non-Invasive Serologic Markers in the Management of Early Allograft Rejection in Liver Transplantation Recipients. Transplantation 1999;68:247-253.
29. Merchant TE, Minsky BD, Lauwers GY, Diamantis PM, Haida T, Glonek T. Esophageal Cancer Phospholipids Correlated with Histopathologic Findings: A P NMR Study. NMR in Biomedicine 1999;12:1-5.
30. Vauthey, J-N, Marsh R de W, Zlotecki RA, Abdalla EK, Solorzano CC, Bray EJ, Freeman ME, Lauwers GY, Kubilis PS, Mendenhall WM, Copeland EM. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 1999;229:745-754.
31. Campbell-Thompson M, Lauwers GY, Reyher KK, Cromwell J, Shiverick KT. 17 b-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N’-nitro guanidine. Endocrinology 1999;140:4886-4894.
32. Scornik JC, Lauwers GY, Reed AI, Howard RJ, Dickson RC, Rosen CB. Infusion of Donor Spleen Cells and Rejection in Liver Transplant Recipients. Clin Transplantation 2000;14:55-60.
33. Lauwers GY, Perez-Atayde A, Dorfman RF, Rosai J. The Digestive System Manifestations of Rosai-Dorfman Disease (Sinus Histocytosis with Massive Lymphadenopathy). Human Pathol 2000;31:380-385.
34. Nelson DR, Lauwers GY, Lau JYN, Davis GL. Interleukin 10 Treatment Reduces Fibrosis in Patients with Chronic Hepatitis C: a Pilot Trial of Interferon Nonresponders. Gastroenterology 2000;118:655-660.
35. Schlemper RJ, Riddell RH, Kato Y, Borchard F, Cooper HS, Dawsey SM, Dixon MF, Fenoglio-Presiser CM, Flejou J-F, Geboes K, Hattori T, Hirota T, Itabashi M, Iwafuchi M, Iwashita A, Kim YI, Kirchner T, Klimpfinger M, Koike M, Lauwers GY, Lewin KJ, Oberhuber G, Offner F, Price AB, Rubio CA, Shimizu M, Shimoda T, Sipponen P, Solcia E, Stolte M, Watanabe H, Yamabe H. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-255
36. Vauthey JN, Chaoui A, Bilimoria M, Do, KA, Charnsangavej C, Hicks M, Alfasser G, Lauwers GY, Hawkins R, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery. 2000;127:512-9.
37. Peen E, Hahn P, Lauwers GY, Gleich G, Kephart GM, Williams RC. Churg-Strauss Syndrome: Localization of Eosinophil Major Basic Protein in Damaged Tissues. Arthritis and Rheumatism, 2000
38. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MH, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington KW. Reproducibility of the diagnosis of dysplasia in Barrett Esophagus (BE): a reaffirmation. Human Pathol 2001; 32:368-378.
39. Montgomery E, Goldblum JR, Greenson JK, Haber MH, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington KW, Zahurak ML, Hart J. Dysplasia as a predictive marker for invasive carcinoma in Barrett’s Esophagus: A follow-up study based on 138 cases from a diagnostic variability study. Human Pathol 2001;32:379-388.
40. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do K-A, Regimbeau JM, Ellis LM, Curley SA, Ikai I, Yamaoka Y, Vauthey JN. Underlying liver disease, not tumor factors predicts long term survival (more than 5 years) after resection of hepatocellular carcinoma. Arch Surg, 2001;136:528-535.
41. Eagle DA, Gian V, Lauwers GY, Manivel JC, Moreb JS, Mastin S, Wingard JR. Gastroparesis following bone marrow transplantation. Bone Marrow Transplant. 2001;28:59-62.
42. Kanehira K, Braylan RC, Lauwers GY. Early phase of intestinal mantle cell lymphoma: A report of two cases associated with advanced colonic adenocarcinoma. Mod Pathol2001;14:811-817.
43. Lauwers GY, Furman J, Michaels LE, Balis UJ. Cytoskeletal and kinetic epithelial differences between NSAID gastropathy and H. pylori gastritis - An immunohistochemical determination. Histopathol 2001;39:133-140
44. Poneros JM, Tearney GJ, Shiskov M, Kelsey PB, Lauwers GY, Nishioka NS, Bouma BE. Optical coherence tomography of the biliary tree during ERCP. Gastrointest Endosc 2002;55:84-88
45. Lauwers GY, Terris B, Balis UJ, Batts KP, Regimbeau JM, Chang Y, Graeme-Cook F, Yamabe H, Ikai I, Cleary KR, Fujita S, Flejou JF, Zukerberg LR, Nagorney D, Belghiti J, Yamaoka Y, Vauthey JN. Prognostic histologic determinants of resected hepatocellular carcinomas. Am J Surg Pathol 2002;26:25-34
46. Balcom JH, Keck T, Antoniu B, Warshaw AL, Lauwers GY, Fernandez-Del Castillo. Perioperative matrix metalloproteinase inhibition therapy does not impair wound or anatomic healing. J Gastrointest Surg. 2002;6:488-495
47. Montgomery E, Bronnner MP, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Goldblum JR. Are ulcers a marker for invasive carcinoma in Barrett’s esophagus? Data from a diagnostic variability study. Am J Gastroenterol 2002;97:22-31
48. Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghit J, Curley SA, Ellis LM, Vauthey JN. Predictors of Microvascular Invasion in Patients with Hepatocellular Carcinoma Who Are Candidates for Orthotopic Liver Transplantation. J Gastrointest Surg. 2002; 6:224-232
49. Vauthey JN, Lauwers GY, Esnaola N, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney D. A Simplified Staging for Hepatocellular Carcinoma. J Clin Oncol 2002;20:1527-36.
50. Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka Y, Regimbeau JM, Nagorney DM, Do KA, Ellis LM, Curley SA, Pollock RE, Vauthey JN. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002 235:722-30.
51. Campo-Ruiz V, Ochoa ER, Lauwers GY, Gonzales S. Evaluation of hepatic histology by near-infrared confocal microscopy: A pilot study. Hum Pathol. 2002 Oct;33(10):975-982.
52. Brand S, Wang TD, Schomacker KT, Poneros JM, Lauwers GY, Compton CC, Pedroa MC, Nishioka NS. Detection of high-grade dysplasia in Barrett’s esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence. Gastrointest Endosc. 2002 Oct;56(4):479-87.
53. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, Van Der Werf W, Lauwers GY, Liu C, Crawford JM, Davis GL, Nelson DR. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl. 2002 Nov;8(11):1000-6.
54. Washington K, Greenson JK, Montgomery E, Shyr Y, Crissinger KD, Polk DB, Barnard J, Lauwers GY. Histopathology of ulcerative colitis in initial rectal biopsy in children. Am J Surg Pathol. 2002 Nov;26(11):1441-9.
55. Deshpande V, Selig MK, Nielsen GP, Lauwers GY. Ductulo-insular Pancreatic endocrine Neoplasms. Clinicopathologic Analysis of a Unique Subtype of Pancreatic Endocrine Neoplasms. Am J Surg Pathol 2003; 27: 461-468.
56. Yantiss RK, Nielsen GP, Lauwers GY, Rosenberg AE. Reactive nodular fibrous pseudotumor of the gastrointestinal tract: a clinicopathologic of four cases. Am J Surg Pathol 2003;27:532-540.
57. Willett CG, Fernandez del Castillo C, Shih HA, Goldberg S, Biggs P, Clark JW, Lauwers GY, Ryan DP, Andrew ZX, Warshaw AL. Long-term results of intraoperative electron beam irradiation for patients with unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S220
58. Mino M, Lauwers GY. Role of Lymphocytic Immunophenotyping in the Diagnosis of Gluten-Sensitive Enteropathy with Preserved Villous Architecture. Am J Surg Pathol 2003; 27:1237-42.
59. Thayer SP, Pasca di Magliano M, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-6.
60. Esnaola NF, Mirza, N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, Yamaoka Y, Curley SA, Ellis LM, Nagorney DM, Vauthey JN Comparison of Clinicopathologic Characteristics and Outcomes after Resection in Patients with Hepatocellular Carcinoma Treated in the United States, France, and Japan. Ann Surg 2003;238:711-9.
61. Akintola-Ogunremi O, Pfeifer JD, Tan BR, Yan Y, Zhu X, Hart J, Goldblum JR, Burgart L, Lauwers GY, Montgomery E, Lewin D, Washington K, Bronner M, Xiao SY, Greenson, JK, Lamps L, Lazenby A, Wang HI. Analysis of Protein Expression and Gene Mutation of c-kit in Colorectal Neuroendocrine Carcinomas. Am J Surg Pathol 2003; 27:1551-8.
62. Lauwers GY, Ban S, Mino M, Ota S, Matsumoto T, Arai S, Chan H-H, Brugge WR, Shimizu M. Endoscopic mucosal resection for gastric epithelial neoplasms. A study of 39 cases with emphasis on the evaluation of specimens and recommendations for optimal pathologic analysis. Mod Pathol 2004; 17:2-8.
63. Chan H-H, Nishioka NS, Mari M, Lauwers GY, Puricelli WP, Collier KN, Bugge WR. Endoscopic Ultrasound (EUS)-guided photodynamic therapy (PDT) of the pancreas: a pilot study. Gastrointest Endosc 2004; 59:95-99.
64. Willett CG, Boucher Y, Di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, Mino M, Cohen KS, Scadden DT, Hartford AC, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Chen HX, Shellito PC, Lauwers GY, Jain RK. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med. 2004;10:145-7. Erratum in: Nat Med. 2004 Jun;10(6):649.
65. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004; 85: 36-41.
66. Vauthey JN, Pawlik TM, Lauwers GY, Nagorney DM, Roh MS, Curley SA, Poon RT, Belghiti J, Greene F, Michael Henderson J. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004; 91:400-408.
67. Barbie DA, Mangi AA, Lauwers GY. Eosinophilic gastroenteritis associated with systemic lupus erythematosus. J Clin Gastroenterol 2004; 38:883-886
68. Deshpande V, Fernandez-del Castillo C, Muzikansky A, Deshpande A, Zukerberg Warshaw AL, Lauwers GY. Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 2004;28:1145-1153
69. Si MW, Thorson JA, Lauwers GY, DalCin P, Furman J. Hepatocellular lymphoepithelioma-like carcinoma associated with epstein barr virus: a hitherto unrecognized entity. Diagn Mol Pathol. 2004;13:183-189.
70. Ban S, Mino M, Nishioka NS, Puricelli W, Zukerberg LR, Shimizu M, Lauwers GY. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett’s esophagus. Am J Surg Pathol 2004;28:1466-1473.
71. Misdraji J, Burgart LJ, Lauwers GY. Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas. Mod Pathol. 2004;17:1447-1454.
72. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR, Lauwers GY, Fernandez CD, Warshaw AL, Simeone JF. Autoimmune pancreatitis: imaging features. Radiology. 2004;233:345-352.
73. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg 2004; 8:794-805.
74. Nielsen CM, Williams J, van den Brink GR, Lauwers GY, Roberts DJ. Hh pathway expression in human gut tissues and in inflammatory gut diseases. Lab Invest. 2004;84:1631-1642
75. Campo-Ruiz V, Lauwers GY, Anderson RR, Delgado-Baeza E, González S. In vivo and ex vivo virtual biopsy of the liver with near-infrared, reflectance confocal microscopy. Mod Pathol 2004.
76. Willett CG, Fernandez del Castillo C, Shih HA, Goldberg S, Biggs P, Clark JW, Lauwers GY, Ryan DP, Zhu AX, Warshaw AL. Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg. 2005 Feb;241(2):295-9.
77. Hornick JL, Lauwers GY, Odze RD. Immunohistochemistry can help distinguish metastatic pancreatic adenocarcinomas from bile duct adenomas and hamartomas of the liver. Am J Surg Pathol. 2005 Mar;29 (3):381-389
78. Lauwers GY, Mino M, Ban S, Forcione D, Shimizu M, Sevestre H. Cytokeratins 7 and 20, and mucin core protein expression in esophageal cervical inlet patch. Am J Surg Pathol. 2005;29:437-442.
79. Mino M, Brugge W, Nishioka N, Puricelli W, Lauwers GY. Management of Superficial Barrett’s Epithelium-Related Neoplasms by Endoscopic Mucosal Resection: Clinicopathologic Analysis of 27 Cases.” Am J Surg Pathol 2005;29:680-686.
80. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, Kianmanesh R, Ng IO, Curley SA, Yamaoka Y, Lauwers GY, Vauthey JN. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137:403-10.
81. Gan SI, Thompson CC, Lauwers GY, Bounds BC, Brugge WR. Ethanol lavage of pancreatic cystic lesions: Initial pilot study. Gastrointest Endosc. 2005;61:746-52.
82. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN; International Cooperative Study Group on Hepatocellular Carcinoma. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg. 2005 ;140:450-7 (discussion 457-8).
83. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT. Is Hepatic Resection for Large or Multinodular Hepatocellular Carcinoma Justified? Results From a Multi-Institutional Database. Ann Surg Oncol. 2005; 12:364-73
84. Ogino S, Kawasaki T, Brahmandam M, Yan L, Cantor M, Namgyal C, Mino-Kenudson M, Lauwers GY, Loda M, Fuchs CS. Sensitive sequencing method for KRAS mutation detection by PyrosequencingTM. J Mol Diagn 2005 2005 ;7:413-421.
85. Tseng JF, Warshaw AL, Sahani DV, Lauwers GY, Rattner DW, Castillo CF. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg. 2005 Sep;242(3):413-421.
86. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005 Sep;11(9):1086-92.
87. Robert ME, Washington MK, Lee JR, Goldenring JR, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart JA, Lamps LW, Lauwers GY, Lewin D, Lazenby AJ, Montgomery E, Crawford JM. Rab11a immunohistochemical analysis does not distinguish indefinite, low-, and high-grade dysplasia in Barrett esophagus. Am J Clin Pathol. 2005 Oct;124(4):1-9.
88. Stanger BZ, Stiles B, Lauwers GY, Bardeesy N, Mendoza M, Wang Y, Greenwood A,Cheng KH, McLaughlin M, Brown D, Depinho RA, Wu H, Melton DA, Dor Y. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell. 2005 8:185-95.
89. Kirley SD, D’Apuzzo M, Lauwers GY, Graeme-Cook F, Chung DC, Zukerberg LR. The cables gene on chromosome 18q regulates colon cancer progression in vivo. Cancer Biol Ther. 2005 Aug 6;4
90. Willett CG, Boucher Y, Duda DG, di Tomaso E, Munn LL, Tong RT, Kozin SV,Petit L, Jain RK, Chung DC, Sahani DV, Kalva SP, Cohen KS, Scadden DT, Fischman AJ, Clark JW, Ryan DP, Zhu AX, Blaszkowsky LS, Shellito PC, Mino-Kenudson M, Lauwers GY. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol. 2005 Nov 1;23(31):8136-9.
91. Deshpande V, Mino-Kenudson M, Brugge WR, Pitman MB, Castillo CF, Warshaw AL, Lauwers GY. Endoscopic ultrasound guided fine needle aspiration biopsy of autoimmune pancreatitis: diagnostic criteria and pitfalls. Am J Surg Pathol. 2005 Nov;29(11):1464-1471.
92. Hull MJ, Mino-Kenudson M, Nishioka NS, Ban S, Sepehr A, Puricelli W, Nakatsuka L, Ota S, Shimizu M, Brugge WR, Lauwers GY. Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg Pathol. 2006;30:114-118.
93. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Perez-Gallego L, Redston M, Tuveson DA. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 2006 Jan 1;66(1):95-106.
94. Evans JA, Poneros JM, Bouma BE, Bressner J, Halpern EF, Shishkov M, Lauwers GY, Mino-Kenudson M, Nishioka NS, Tearney GJ. Using optical coherence tomography to identify intramucosal carcinoma and high grade dysplasia in Barrett’s esophagus. Clin Gastroent Hepatol 2006 Jan;4(1):38-43.
95. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C,Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA,Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-daymortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006 24:2065-72.
96. Farrell JJ, Lauwers GY, Brugge WR. Endoscopic mucosal resection using a cap-fitted endoscope improves tissue resection and pathology interpretation: an animal study. Gastric Cancer. 2006;9:3-8
97. Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations–correlation with MRCP. Radiology. 2006 ;238:560-9.
98. Campo-Ruiz V, Lauwers GY, Anderson RR, Delgado-Baeza E, Gonzalez S. Novel virtual biopsy of the kidney with near infrared, reflectance confocal microscopy: a pilot study in vivo and ex vivo. J Urol. 2006;175:327-36.
99. Mitsuhashi T, Lauwers GY, Ban S, Mino-Kenudson M, Shimizu Y, Ogawa F, Ota S, Shimizu M. Post-gastric endoscopic mucosal resection surveillance biopsies: Evaluation of mucosal changes and recognition of potential mimics of residual adenocarcinoma. Am J Surg Pathol 2006;30(5):650-656.
100. Kwak EL, Jankowski J, Thayer SP, Lauwers GY, Brannigan BW, Harris PL,Okimoto RA, Haserlat SM, Driscoll DR, Ferry D, Muir B, Settleman J, Fuchs CS, Kulke MH, Ryan DP, Clark JW, Sgroi DC, Haber DA, Bell DW. Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas. Clin Cancer Res. 2006;12:4283-7.
101. Ban S, Naito Y, Mino-Kenudson M, Sakurai T, Kuroda M, Koyama I, Lauwers GY, Shimizu M. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathological difference between two major types. Am J Surg Pathol. 2006;30:1561-9.
102. Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, Olson P, Hezel AF, Horner J, Lauwers GY, Hanahan D, Depinho RA. Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev. 2006;20(22):3130-46.
103. Deshpande V, Chicano S, Finkelberg D, Selig MK, Mino-Kenudson M, Brugge WR, Colvin RB, Lauwers GY. Autoimmune pancreatitis: a systemic igg4 immune complex mediated disease. Am J Surg Pathol . Am J Surg Pathol. 2006;30:1537-45. Erratum in: Am J Surg Pathol. 2007
104. Mino-Kenudson M, Tomita S, Lauwers GY. Mucin expression in reactive gastropathy: An immunohistochemical analysis. Arch Pathol Lab Med. 2007;131(1):86-90.
105. Mino-Kenudson M, Ban S, Ohana M, Puricelli W, Deshpande V, Shimizu M, Nishioka NS, Lauwers GY. Buried Dysplasia and Early Adenocarcinoma Arising in Barrett’s Esophagus after Porfimer-Photodynamic Therapy. Am J Surg Pathol 2007;31:403-9.
106. Deshpande V, Lauwers GY. Cystic pancreatic endocrine tumor: A variant commonly confused with cystic adenocarcinoma. Cancer Cytopathology. 2007; 25:47-53.
107. Evans JA, Bouma BE, Bressner J, Shishkov M, Lauwers GY, Mino-Kenudson M, Nishioka NS, Tearney GJ. Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc. 2007;65:50-6.
108. Vagefi PA; Razo O; Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernandez-del Castillo C. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms. The Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007;142:347-354
109. Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, Hong SM, Hytiroglou P, Kloppel G, Lauwers GY, van Leeuwen DJ, Notohara K, Oshima K, Quaglia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20:701-9.
110. Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernandez-Del Castillo C. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-9; .
111. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297:2360-72.
112. Cornell LD, Chicano SL, Deshpande V, Collins AB, Selig MK, Lauwers GY, Barisoni L, Colvin RB. Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol. 2007;31:1586-1597.
113. Koreishi A, Lauwers GY, Misdraji J. Pneumatosis intestinalis: a challenging biopsy diagnosis. Am J Surg Pathol. 2007;31:1469-75.
114. Strobel O, Dor Y, Alsina J, Stirman A, Lauwers GY, Trainor A, Fernandez-del Castillo C, Warshaw AL, Thayer SP. In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia. Gastroenterology 2007;133:1999-2009.
115. Park D-Y, Sakamoto H, Kirley SD, Ogino S, Kawasaki T, Kwon E, Mino-Kenudson M, Lauwers GY, Chung DC, Rueda BR, Zukerberg LR. The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol 2007;171:1509-19.
116. Rodríguez JR, Salvia R, Crippa S, Bassi C, Pederzoli P, Capelli P, Lauwers GY, Mino-Kenudson M, McGrath D, Razo O, Thayer SP, Warshaw AL, Fernández-del Castillo C. Branch duct intraductal papillary mucinous neoplasms of the pancreas (IPMNs): Confirmed findings in 145 resected patients. Gastroenterology 2007;133:72-9; quiz 309-10.
117. Mino-Kenudson M, Hull MJ, Brown I, Muzikansky A, Srivastava A, Glickman J, Park DY, Zuckerberg L, Misdraji J, Odze RD, Lauwers GY. Endoscopic mucosal resection for Barrett’s esophagus related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastroint Endoscopy 2007 Oct;66(4):660-6; quiz 767, 769.
118. Vagefi PA, Razo O, Deshpande V, McGrath DJ, Lauwers GY, Thayer SP, Warshaw AL, Fernandez-Del Castillo C. Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005. Arch Surg. 2007;142(4):347-54.
119. Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, Hong SM, Hytiroglou P, Kloppel G, Lauwers GY, van Leeuwen DJ, Notohara K, Oshima K, Quaglia A, Sasaki M, Sessa F, Suriawinata A, Tsui W, Atomi Y, Nakanuma Y. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007;20(6):701-9.
120. Srivastava A, Odze RD, Lauwers GY, Redston M, Antonioli DA, Glickman JN. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia. Am J Surg Pathol. 2007;31(11):1733-41.
121. Farris AB, Misdraji J, Srivastava A, Muzikansky A, Deshpande V, Lauwers GY, Mino-Kenudson M. Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol 2008;32:30-35.
122. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008;299(1):53-60.
123. Hornick JL, Mino-Kenudson M, Lauwers GY, Liu W, Goyal R, Odze RD. Buried Barrett’s epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2008;103:38-47.
124. Beppu H, Mwizerwa ON, Beppu Y, Dattwyler MP, Lauwers GY, Bloch KD, Goldstein AM. Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene. 2008. 27:1063-70.
125. Willingham FF, Gee DW, Lauwers GY, Brugge WR, Rattner DW. Natural orifice transesophageal mediastinoscopy and thoracoscopy. Surg Endosc 2008;22:1042-7.
126. Park DP, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V, Zukerberg LR, Song GA, Lauwers GY. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Path 2008;32:524-33.
127. Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshpande V. Serous cystadenoma of the pancreas: Limitations and pitfalls of EUS guided fine needle aspiration biopsy. Cancer 2008;114:102-10.
128. Crippa S, Salvia R, Warshaw AL, Domínguez I, Bassi C, Falconi M, Thayer SP, Zamboni G, Lauwers GY, Mino-Kenudson M, Capelli P, Pederzoli P, Castillo CF. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg. 2008;247(4):571-579.
129. Farris AB, Lauwers GY, Ferry JA, Zukerberg LR. The rectal tonsil: a reactive lymphoid proliferation that may mimic lymphoma. Am J Surg Pathol 2008:32:1075-9.
130. Oble DA, Mino-Kenudson M, Goldsmith J, Hodi FS, Dranoff G, Mihm M, Hasserjian R, Lauwers GY. a-CTLA-4 mAb associated panenteritis: A histologic and immunohistochemical analysis. Am J Surg Pathol 2008;32:1130-7.
131. Hornig M, Briese T, Buie T, Bauman ML, Lauwers G, Siemetzki U, Hummel K, Rota PA, Bellini WJ, O’Leary JJ, Sheils O, Alden E, Pickering L, Lipkin WI. Lack of association between measles virus vaccine and autism with enteropathy: a case-control study. PLos ONE 2008;3:e3140.
132. Sabo E, Meitner PA, Tavares R, Corless CL, Lauwers GY, Moss SF, Resnick MB. Expression analysis of Barrett’s esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. Clin Cancer Res. 2008;14(20):6440-8.
133. Suter MJ, Vakoc BJ, Yachimski PS, Shishkov M, Lauwers GY, Mino-Kenudson M, Bouma BE, Nishioka NS, Tearney GJ. Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc. 2008;68(4):745-753.
134. Gee DW, Willingham FF, Lauwers GY, Brugge WR, Rattner DW. Natural orifice transesophageal mediastinoscopy and thoracoscopy: a survival series in swine. Surg Endosc. 2008;22(10):2117-22.
135. Sepehr A, Mino-Kenudson M, Ogawa F, Brugge WR, Deshpande V, Lauwers GY. IgG4+ To IgG+ plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other “mass forming” pancreatic lesions. Am J Surg Pathol 2008;32:1770-9.
136. Weylandt KH, Nadolny A, Kahlke L, Köhnke T, Schmöcker C, Wang J, Lauwers GY, Glickman JN, Kang JX. Reduction of inflammation and chronic tissue damage by omega-3 fatty acids in fat-1 transgenic mice with pancreatitis Omega-3 fatty acids alleviate acute and chronic pancreatitis. Biochim Biophys Acta 2008;1782:634-41.
137. Ogawa F, Mino-Kenudson M, Shimizu M, Ligato S, Lauwers GY. Yttrium-90 microsphere selective internal radiation-associated gastroduodenitis. Arch Pathol Lab Med 2008;132:1734-8.
138. Harris EI, Lewin DN, Wang HL, Lauwers GY, Srivastava A, Shyr Y, Shakhtour B, Revetta F, Washington MK. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am J Surg Pathol 2008;32:1816-21.
139. Mandal RV, Forcione DG, Brugge WR, Nishioka NS, Mino-Kenudson M, Lauwers GY. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia. Am J Surg Pathol 2009;33:620-5.
140. Ryan JL, Morgan DR, Dominguez RL, Thorne LB, Elmore SH, Mino-Kenudson M, Lauwers GY, Booker JK, Gulley ML. High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest 2009;89:80-90.
141. Kojiro M, Wanless IR, Alves V, Badve S, Balabaud C, Bedosa P, Bhathal P, Bioulac-Sage P, Brunt EM, Burt AD, Craig JR, Dhillon A, Ferrell L, Geller SA, Goodman ZD, Gouw AS, Guido M, Guindi M, Hytiroglou P, Kage M, Kondo F, Kudo M, Lauwers GY, Nakano M, Paradis V, Park YN, Quaglia A, Roncalli M, Roskams T, Ruebner B, Sakamoto M, Saxena R, Theise ND, Thung S, Taniakos D. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 2009;49:658-64.
142. Jordan KW, Nordenstam J, Lauwers GY, Rothenberger DA, Alavi K, Garwood M, Cheng LL. Metabolomic characterization of human rectal adeno-carcinoma with intact tissue magnetic resonance spectroscopy. Dis Colon Rectum 2009;52:520-5.
143. Fritz S, Fernandez-del Castillo C, Mino-Kenudson M, Crippa S, Deshpande V, Lauwers GY, Warshaw AL, Thayer SP, Iafrate AJ. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg 2009;249:440-7.
144. Park DP, Srivastava A, Kim GH, Mino-Kenudson M, Deshpande V, Zukerberg LR, Song
GA, Lauwers GY. CDX2 Expression in intestinal type gastric epithelial neoplasia:
frequency and significance. Mod Pathol (in press).
145. Lisovsky MY, Dresser K, Baker S, Fisher A, Woda B, Banner B, Lauwers GY. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: An immunohistochemical study. Mod Pathol (in press).
Proceedings of Meetings
1. Ioachim H, Lauwers GY, Weinstein M, Sohn N. Condyloma, Bowen’s disease, and squamous cell carcinoma in homosexual men. Proceedings of the IV International Conference on AIDS, Stockholm, Sweden, 1988.
2. Lauwers GY, Cronin W, Ioachim H. Human papilloma virus (HPV) in anal Bowen’s disease. Proceedings of the V International Conference AIDS, Montreal, Canada, 1989.
3. Lauwers GY, Cronin W, Shevchuk M. Pancreatic fibrosis in AIDS: potential role of HIV. Proceedings of 2nd Lenox Hill Hospital Research Conference, pp. 23‑24, 1990.
4. Faber S, Lauwers GY, Rojas‑Corona R, Korelitz B. Neural patterns in Crohn’s disease: an immunohistochemical survey. Proceedings of the 2nd Lenox Hill Hospital Research Conference, pp 23‑24, 1990.
5. Ioachim HL, DaSilva M, Shevchuk MM, Lauwers GY, Cronin WJ. Pathology of male genital organs associated with the HIV infection and AIDS. In: Melica F (Editor.) AIDS and Human Reproduction,(1st International Symposium, AIDS and Reproduction, Genoa, 1990), Karger, Basel, pp 124‑134, 1992.
6. Shriver CD, Lauwers GY, Karpeh M, Brennan MF, Burt ME. Is Barrett’s adenocarcinoma or gastroesophageal junction adenocarcinoma the worse disease? In: Proceedings of the Society of Surgical Oncology, 46th Annual Cancer Symposium, Los Angeles, Ca. March 18‑21, 1993.
7. Kelsen D, Gerdes H, Schwartz G, Saltz L, Karpeh M, Yao TJ, Christman K, Lauwers GY, Friedrich C, Brennan MF, Lightdale C. Endoscopic ultrasonography (EUS) as a measure of response to chemotherapy to gastric cancer. Proceedings of ASCO Annual Meeting, Orlando, Florida, May 16‑18, 1993.
8. Fein J, Gerdes H, Karpeh M, Lauwers GY, Botet JF, Kelsen D, Brennan MF, Lighdale C. Overstaging of ulcerated gastric cancers by endoscopic ultrasonography. Proceedings of ASGE Annual Meeting, Boston, MA, May 18‑19, 1993.
9. Karpeh M, Marrero A, Lauwers GY, Cordon Cardo C, Brennan M. Is p53 overexpression of prognostic significance in early gastric carcinoma? In: Proceedings of the Society of Surgical Oncology, 47th Annual Cancer Symposium, Houston, TX March, 1994
10. Lauwers GY, Scott GV, Hendricks J. Aberrant bcl-2 protein expression in gastric epithelial dysplasia. An immunohistochemical study. XVII Annual Seminar of Cancer Research in Florida. Sponsored by the American Cancer Society, Florida Division, Inc. Orlando, Florida March 5, 1994.
11. Grant LD, Lauwers GY, Meloni AM, Betz JL, Stone JF, Sanberg AA. Unbalanced Chromosomal Translocation der(17)t(13;17) (q14;p11) in Solid Cystic Papillary Epithelial Neoplasm of the Pancreas. 6th International Workshop on Chromosomes in Solid Tumors. Tucson, Az. Feb. 19-21, 1995.
12. “Gastric neoplasia after Vienna.” In “Upper Gastrointestinal Pathology,” XXIVth International Congress of the International Academy of Pathology. Amsterdam, The Netherlands, October 7,2002
13. Stein SL, Warshaw AL, Fernández-del Castillo C, Lauwers GY, Sahani D, Thayer SP. Autoimmune pancreatitis masquerading as pancreatic cancer: a diagnostic dilemma (abstract). Proceedings, 84th Annual Meeting, New England Surgical Society, Newport, RI, Sept. 19-23, 2003.
14. “Drug induced and iatrogenic pathology of the stomach.” In: “Iatrogenic Pathology of the GI Tract,” XXVth International Congress of the International Academy of Pathology. Brisbane, Australia, Oct.12, 2004.
Reviews, Chapters, and Editorials
1. Lauwers GY. Mucosal dysplasia in inflammatory bowel disease. In: Management of Inflammatory Bowel Disease, Korelitz B, Sohn N, Eds, Mosby‑Yearbook, Inc., St. Louis, MO, pp 187‑198, 1992.
2. Lauwers GY. Contribution of endoscopic biopsy specimens to the histologic grading of gastric lymphoma. Adv Gastroenterol Hepatol Clin Nutr 1997; 5:192-194.
3. Lauwers GY. Evaluation of micrometastasis for esophageal cancer - is it relevant? Adv Gastroenterol Hepatol Clin Nutr 1998;3:183-185.
4. Lauwers GY, Vauthey JN. Pathological aspects of hepatocellular carcinoma: a critical review of histologic prognostic factors. Hepatogastroenterol 1998;45:1197-1201.
5. Fujita S, Lauwers GY. Primary hepatic malignant fibrous histiocytoma. report of a case and review of the literature. Pathol Int 1998;48:225-229.
6. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999;45:784-790.
7. Abdalla EK, Forsmark CE, Lauwers GY, Vauthey J-N. Monolobar Caroli’s disease and carcinoma: case report and review of the literature. HPB Surgery 1999;11:271-277.
8. Furman J, Lauwers GY. Clear cell change in colonic adenocarcinoma, an equally unusual finding. Histopathology 1999;35:476-477 (See corrigendum 2000;36:191).
9. Lauwers GY, Novak D. Bacterial, parasitic and fungal infection of the liver. In: Suchy FJ, Sokol RJ, Balistreri WF (Eds.) Liver Diseases in Children, 2nd edition, Lippincott Williams & Wilkins, Philadelphia, 2000.
10. Lauwers GY. Pathology of Hepatocellular Carcinoma, In: Kelsen DP, Tepper, Levin B, Kern SE, Daly M. (Editors) Principles and Practice of Gastrointestinal Oncology. Lippincott Williams & Wilkins, Philadelphia.
11. Lauwers GY, Shimizu M. Pathology of Gastric Carcinoma. In: Rustgi AK, Crawford JM (Editors) Gastrointestinal Cancers, 1st Edition, W.B. Saunders, Philadelphia 2000.
12. Pitman MB, Lauwers GY. Cytohistologic evaluation of the liver: Imprint and smear cytology and intraoperative frozen section. Pathology Case Reviews. 2001;6;218-224.
13. Lauwers GY. Gastric dysplasia, diagnosis and significance. Pathology Case Reviews 2002 ;7:27-34.
14. Goldblum JR, Lauwers GY. Dysplasia arising in Barrett’s esophagus: Diagnostic pitfalls and natural history. Sem Diag Pathol 2002;19:12-19.
15. Misdraji J, Lauwers GY. Gastric Epithelial Dysplasia. Sem Diag Pathol 2002;19:20-30
16. Adsay NV, Hasteh F, Cheng JD, Bejarano PA, Lauwers GY, Batts KP, Kloppel G, Klimstra DS Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol. 2002;15:492-501.
17. Mino, M, Lauwers GY. Pathological spectrum and prognostic significance of underlying liver disease in hepatocellular carcinoma. Surg Oncol Clin N Am. 2003;12:13-24.
18. Balis UJ, Lauwers GY. Pathology and Natural History of Hepatocellular Carcinoma. In: The Practice of Gastrointestinal Oncology. Abbruzzese JL, Willett C. (Eds.) Oxford University Press, New York, NY 2003.
19. Esnaola NF, Vauthey JN, Lauwers GY. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (Br J Surg 2002; 89: 57-62). Br J Surg. 2002 Jul;89(7):939-40.
20. Lauwers GY. Hepatocellular Carcinoma: Pathological indicators of prognosis in Malignant Liver Tumors: Basic Concepts and Clinical Manangement. Berr F., Bruix J, Hauss J, Wands J, Wittekind Ch.(Eds.) 2003, pp. 75-86
21. Vauthey JN, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest? J Hepatol. 2003 Feb;38(2):237-9. (Editorial)
22. Lauwers GY, Shimizu M. Pathology of gastric carcinoma, in Gastrointestinal Cancers (companion to Sleisenger and Fordtran’s Gastrointestinal and Liver diseases) Rustgi AK (Ed.) W.B. Saunders, Philadelphia. 2003, pp. 321-330
23. West AB, Fisher R, Kapadia C, Genta R, Wang T, Lauwers GY. What and whom to treat with metaplasia? J Clin Gastroenterol. 2003 May-Jun;36(5):S61 (Editorial)
24. Lauwers G.Y. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and adenocarcinoma. J. Clin Gastroenterol 2003;36:S37-43 (Review)
25. Mino M, Lauwers GY. Pathological spectrum and prognostic significance of underlying liver disease in hepatocellular carcinoma. Surg Oncol Clin N Am 2003;12:13-24.
26. Brugge WR, Lauwers GY, Sahani D, Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. N Engl J Med 2004;351: 1218-26. (Review)
27. Lauwers GY. Epithelial Neoplasms of the Stomach. In: Odze RD, Goldblum JR, Crawford JM (Ed.) Surgical Pathology of the GI Tract, Biliary Tract, and Pancreas. 1st ed. Philadelphia, PA: W.B. Saunders, 2004, pp. 409-428.
28. Mino Mari, Lauwers GY. Pathology of Periampullary Tumors. In, Pancreatic Cancer. Von Hoff DD, Evans DB, Hruban RH. (Eds). Jones and Barlett Publishers, 2005; pp 686-702
29. Vauthey JN, Lauwers GY. Surgically resected hepatocellular carcinoma: protean yet predictable. Ann Surg Oncol. 2005 Apr;12(4):270-272. (Editorial)
30. Mino-Kenudson M., I. Brown I., Lauwers GY. Histopathological diagnosis of gluten-sensitive enteropathy. Current Diagnostic Pathology. 2005;11:274-283 (Review)
31. Autoimmune pancreatitis: more than just a pancreatic disease? A contemporary review of its pathology. Deshpande V, Mino-Kenudson M, Brugge WR, Lauwers GY. Arch Pathol Lab Med. 2005 Sep;129(9):1148-54. (Review)
32. Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med. 2006 Jul;130(7):1020-5. (Review)
33. Bartlett DL, Berlin J, Lauwers GY, Messersmith WA, Petrelli NJ, Venook AP. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006;13:1284-92
34. Misdraji J, Oliva E, Goldblum JR, Lauwers GY, Compton CC; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with invasive carcinomas of the appendix. Arch Pathol Lab Med. 2006;130:1433-9.
35. Lauwers GY, Chung DC. The serrated polyp comes of age. Gastroenterology. 2006;131:1631-4.
36. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg. 2007;94:274-86. (Review)
37. Srivastava A, Lauwers GY. Pathology of non-infective gastritis. Histopathology. 2007;50:15-29. (Review)
38. Campbell F, Lauwers GY, Williams GT. Tumors of the esophagus and stomach. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumors. 3rd ed. Edinburgh: Churchill Livingstone; 2007:327-77.
39. Deshpande V, Lauwers GY. Hepatocellular Cancer: Pathology. In: Kelsen DP, Tepper, Levin B, Kern SE, Daly M, eds. Principles and Practice of Gastrointestinal Oncology. 2nd ed. Lippincott Williams & Wilkins, Philadelphia. 2007:419-427.
40. Lauwers GY, Srivastava A. Gastric pre-neoplastic lesions and epithelial dysplasia. (Review) Gastroenterology Clinics of North America. 2007;36:813-29.
41. Shields HM, Shaffer K, O’Farrell RP, Travers R, Hayward JN, Becker LS, Lauwers GY. Gastrointestinal manifestations of dermatologic disorders. Clin Gastroenterol Hepatol 2007;5:1010-1017.
42. Lauwers GY. Biopsy pathology in colorectal disease. Arch Pathol Lab Med. 2007 Dec;131:1837
43. Lauwers GY, Srivastava A. Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am. 2007;36:813-29, vi. (Review)
44. Lauwers GY, Mino-Kenudson M, Rubin R. The pancreas. In: Rubin R, Strayer DS, eds. Rubin’s Pathology: Clinicopathologic Foundations of Medicine. 5th ed. Baltimore, MD and Philadelphia, PA: Lippincott Williams & Wilkins; 2007:675-89.
45. Robert ME, Lamps L, Lauwers GY; on behalf of the Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of gastric carcinoma. Hum Pathol 2008 Jan;39(1):9-14. (Review)
46. Lauwers GY. Park DY. Gastric polyps: classification and management. Arch Pathol 2008;132:633-40. (Review)
47. Lauwers GY, Srivastava A. Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am. 2007 Dec;36(4):813-29, vi. (Review)
48. Takayama T, Makuuchi M, Kojiro M, Lauwers GY, Adams RB, Wilson SR, Jang HJ, Charnsangavej C, Taouli B. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol. 2008 Apr;15(4):972-8. (Review)
49 Srivastava A, Lauwers GY. Gastric epithelial dysplasia: the Western perspective. Dig Liver Dis 2008;40(8):641-9. (Review)
50. Graeme-Cook, F, Lauwers GY. Tumors of the pediatric esophagus and stomach. In: Kleinman RE, Sanderson IR, Goulet O et al., eds. Walker’s Pediatric Gastrointestinal Disease: Physiology, Diagnosis, Management. 5th ed. Hamilton: BC Decker; 2008:175-185. (Chapter)
51. Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy 2008;40:1008-15. (Review)
Clinical Communications-Case Reports
1. Lauwers GY, deRoux S., Terzakis, J. Leiomyoma of the breast. Arch Anat Cyto Path 1990; 38:108-110.
2. Lauwers GY, Wahl S, Richard G. Osseous metaplasia in colonic adenocarcinoma. Am J Gastroenterol 86:382, 1991.
3. Lauwers GY, Wahl S, Urmacher C. Multifocal ectopic gastric mucosa of the cervical esophagus. Am J Gastroenterol 86:793-794, 1991.
4. Lauwers GY, Pendergast N, Wahl S, Bagchi S. Invagination of the vermiform appendix. Dig Dis Sci 1993; 38:565-568.
5. Lauwers GY, Wahl SJ, Scott GV, deRoux SJ. Papillary mucinous adenoma arising in adenomatous hyperplasia of the gall bladder. J Clin Pathol 1995; 48:965-967.
6. Grant LD, Lauwers GY, Meloni AM, Betz JL, Stone JF, Vogel SB, Sandberg A. Unbalanced chromosomal translocation, der (17)t(13;17)(q14;p11) in solid and cystic papillary epithelial neoplasm of the pancreas. Am J Surg Pathol 1996; 20:339-345.
7. Lauwers GY, Grant LD, Donnelly WH, Meloni AM, Foss RM, Sanberg AA, Langham MR Jr. Hepatic Undifferentiated (Embryonal) Sarcoma Arising in a Mesenchymal Hamartoma. Am J Surg Pathol 1997;10:1248-54.
8. Lauwers GY, Scott GV, Vauthey JN. Adenocarcinoma of the Upper Esophagus Arising in Cervical Ectopic Gastric Mucosa. Dig Dis Sci 1998;43:901-907.
9. Fujita S, Lauwers GY. Primary Hepatic Malignant Fibrous Histiocytoma Report of a Case and Review of the Literature. Pathol Int 1998;48:225-229.
10. Chaoui A, Mergo PJ, Lauwers GY. Unusual Appearance of Focal Nodular Hyperplasia with Fatty Change. AJR 1998;171:1433-4.
11. Abdalla EK, Forsmark CE, Lauwers GY, Vauthey J-N. Monolobar Caroli’s Disease and Carcinoma: Case Report and Review of the Literature. HPB Surgery 1999;11:271-277.
12. Mortele KJ, Lauwers GY, Mergo PJ. Perineal angiomyofibroblastoma: CT and MR findings with pathologic correlation. J Comput Assist Tomogr 1999;5:687-689
13. Ashley SW, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2002. A 69-year-old man with painful cutaneous nodules, elevated lipase levels, and abnormal results on abdominal scanning. Engl J Med. 2002;347:1783-91.
14. Fernandez-del Castillo CF, Sahani DV, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med. 2003;349:893-901.
15. Kelsey PB, Chen S, Lauwers GY. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-2003. A 79-year-old man with coronary artery disease, peripheral vascular disease, end-stage renal disease, and abdominal pain and distention. N Engl J Med 2003;349:2147-55.
16. Varnholt H, Vauthey JN, Cin PD, Marsh R de W, Bhathal PS, Hughes NR, Lauwers GY. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol. 2003;27:693-8.
17. Zhu AX, Lauwers GY, Tanabe KK. Cholangiocarcinoma in Association with Thorotrast Exposure. J Hepatobiliary Pancreat Surg. 2004;11(6):430-3. 18.
18. Tanabe KK, Blaszkowsky LS, Chung RT, Blake MA, Lauwers GY. Case records of the Massachusetts General Hospital. Case 23-2005. A 57-year-old man with a mass in the liver. N Engl J Med. 2005;353:401-10.
19. Nishioka NS, Lauwers GY. Case records of the Massachusetts General Hospital. Case 10-2006. A 66-year-old woman with Barrett’s esophagus with high-grade dysplasia. N Engl J Med. 2006;354(13):1403-9
20. Kradin RL, Badizadegan K, Auluck P, Korzenik J, Lauwers GY. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006;130:718-20.
21. Bendell JC, Lauwers GY, Willett C, Clark JW, Warshaw AL, Wain JC, Ryan DP. Pancreatoblastoma in a teenage patient. Clin Adv Hematol Oncol. 2006;4(2):150-3; discussion 154.
22. Chen CY, Chi KH, George RW, Cox DL, Srivastava A, Rui Silva M, Carneiro F, Lauwers GY, Ballard RC. Diagnosis of gastric syphilis by direct immunofluorescence staining and real-time PCR testing. J Clin Microbiol. 2006;44:3452-6.
23. Hoppin AG, Katz ES, Kaplan LM, Lauwers GY. Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med.2006;355:1593-602.
24. Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol. 2007;4:316-21.
25. Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol. 2007;4(5):316-21.
26. Chung DC, Yoon SS , Lauwers GY, Patel D. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med. 2007;357(3):283-91.
27. Merritt R, Zeitels SM, Austen WG Jr, Lauwers GY, Gaissert HA. Staged closure of tracheogastrocutaneous fistula after esophagectomy for infiltrative granular cell tumor. J Thorac Cardiovasc Surg. 2007;134:805-7.
28. Willett CG, Duda DG, di Tomaso E, Boucher Y, Czito BG, Vujaskovic Z, Vlahovic G, Bendell J, Cohen KS, Hurwitz HI, Bentley R, Lauwers GY, Poleski M, Wong TZ, Paulson E, Ludwig KA, Jain RK. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol. 2007;4:316-21.
29. Chatelain D, Brevet M, Fuks D, Yzet T, Verhaeghe P, Regimbeau JM, Lauwers G, Sevestre H. Inflammatory fibroid polyp, a rare tumor of the appendix. Gastroenterol Clin Biol. 2008;32:274-277.
30. Sepehr A, Lauwers GY. Gastrointestinal evidence of autoimmune pancreatitis: a rare manifestation. Histopathology. 2008;53:358-9.
Letters
1. Lauwers GY, Ioachim H. Testicular atrophy in AIDS patients. Mod Pathol 3:97‑99, 1990.
2. Lauwers GY. Cytomegalovirus infection of the appendix in AIDS patients. Gastroenterol 102:379‑380, 1992.
3. Lauwers GY, Melamed J. Dysplasia in inflammatory bowel disease. N Engl J Med 326:574‑575, 1992.
4. Erlandson RA, Lauwers GY, Woodruff JM. Gastrointestinal Autonomic Nerve Tumors and Skeinoid Fibers. Am J Surg Pathol 1994;18:959-60.
5. Vauthey JN, Walsh GL, Vlastos G, Lauwers GY. Importance of field cancerisation in clinical oncology. Lancet Oncology 2000;1:15-16.
6. Delbecque K, Legrand M, Boniver J, Lauwers GY, de Leval L. Calcifying fibrous tumour of the gastric wall. Histopathology 2004;44:399-400.
7. Vauthey JN, Pawlik TM, Lauwers GY, Nagorney DM, Roh MS, Curley SA, Poon RT, Belghiti J, Greene F, Michael Henderson J. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004; 91: 1072.
8. Pawlik TM, Abdalla EK, Thomas M, Roh MS, Lauwers GY, Ribero D, Poon RT,Belghiti J, Nagorney DM, Vauthey JN. Staging of hepatocellular carcinoma. Hepatology. 2005 Sep;42(3):738-739.
9. Choi MY, Lauwers GY, Hur C, Willett CG, Chung DC. Microsatellite instability is frequently observed in rectal cancer and influenced by neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1584.
Educational Materials
1. Course Syllabus, ASCP Workshop. “Gastric pathology: an updated review and practical approach to diagnosis.” Spring Meeting, Boston 1996.
2. Course Syllabus, ASCP Workshop. “Gastric pathology: an updated review and practical approach to diagnosis.” Fall Meeting, Philadelphia, 1997.
3. Course Syllabus, ASCP Workshop. “Gastric pathology: an updated review and practical approach to diagnosis.” Spring Meeting, New Orleans, 1999.
4. Course Syllabus, “Liver biopsy interpretation, emphasizing commonly encountered problems in daily practice.” Current Concepts in Surgical Pathology. Massachusetts General Hospital 22nd Annual Course, Boston, MA, 2001.
5. Course Syllabus, “Solitary Liver Masses: Benign and Malignant.” Current Concepts in Surgical Pathology. Massachusetts General Hospital 22nd Annual Course, Boston, MA, 2001.
6. Course Syllabus, “Solitary Liver Masses: Benign and Malignant.” Current Concepts in Surgical Pathology, 24th Annual Course. Harvard Medical School and MGH Course, Boston, MA, November 13, 2002.
7. Course Syllabus, “Colitides: an algorithmic approach to the diagnosis.” Current Concepts in Surgical Pathology, 24th Annual Course. Harvard Medical School and MGH Course, Boston, MA, November 15, 2002.
8. Course Syllabus, “Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Chicago, IL, Spring 2003.
9. Course Syllabus, “Colitis: An algorithmic approach emphasizing new entities.” Current Concepts in Surgical Pathology. Massachusetts General Hospital 25th Annual Course, Boston, MA, 2003.
10. “Polypoid lesions of the stomach.” Current Concepts in Surgical Pathology. Massachusetts General Hospital 25th Annual Course, Boston, MA, 2003.
11. “A practical approach to the diagnosis of colitis.” Current Concepts in Surgical Pathology. Massachusetts General Hospital 25th Annual Course, Boston, MA, 2003.
12. Course Syllabus, MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. “Inflammatory Bowel Disease: Criteria for Diagnosis Including Dysplasia.” Ft. Myers, FL. March 27, 2004.
13. Course Syllabus, MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. “Colitis Other Than Inflammatory Bowel Disease.” Ft. Myers, FL, 2004.
14. Course Syllabus, MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. “Gastric Pathology Emphasizing Gastritis, Polyps, and Their Complications.” Ft. Myers, FL, 2004.
15. Course Syllabus, MGH Surgical Pathology for the Practicing Pathologist: Selected Topics. “The Solitary Liver Mass: Problems in Interpretation.” Ft. Myers, FL, 2004.
16 Course Syllabus, “Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Santa Fe, NM, 2004.
17. Course Syllabus, “Interpreting Esophageal and Gastric Biopsies.” Combined BWH, BID, & MGH Comprehensive Review of Gastroenterology Course, Boston, MA, 2004.
18. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, 2004.
19. Course Syllabus, “Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, 2004.
20. Course Syllabus, “Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, 2004.
21. Course Syllabus, “Polyps and Tumors of the Stomach.” Surgical Pathology of the Gastrointestinal Tract. American Society for Clinical Pathology, Rancho Mirage, CA, 2005.
22. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 9-12, 2005.
23. Course Syllabus, “Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 9-12, 2005.
24. Course Syllabus, “Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 9-12, 2005.
25. Course Syllabus, “Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 9-12, 2005.
26. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 1-4, 2006.
27. Course Syllabus, “Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 1-4, 2006.
28. Course Syllabus, “Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 1-4, 2006.
29. Course Syllabus, “Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 1-4, 2006.
30. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 7-10, 2007.
31. Course Syllabus, “Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 7-10, 2007.
32. Course Syllabus, “Pathology of the appendix.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 7-10, 2007.
33. Course Syllabus, “Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 7-10, 2007.
34. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 5-8, 2008.
35. Course Syllabus, “Systemic disorders of the gastrointestinal tract.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 5-8, 2008.
36. Course Syllabus, “Non-IBD colitis.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 5-8, 2008.
37. Course Syllabus, “Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course. Boston, MA, May 5-8, 2008.
38. Course Syllabus, “Inflammatory Bowel Disease: Histologic Controversies and Solutions.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March 20-23, 2009.
39. Course Syllabus, “Other Forms of Colitis: Survey of Their Broad Spectrum.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March 20-23, 2009.
40. Course Syllabus, “Gastritis and Gastropathies, Other than H. Pylori Gastritis.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March 20-23, 2009.
41. Course Syllabus, “Gastric Tumors: An Update.” Harvard Medical School, Surgical Pathology for the Practicing Pathologist, Boston, MA, March 20-23, 2009.
42. Course Syllabus, “Biopsy diagnosis of inflammatory diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
43. Course Syllabus, “Biopsy diagnosis of neoplastic diseases of the stomach.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
44. Course Syllabus, “Non-IBD colitis.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
45. Course Syllabus, “Gastrointestinal manifestations of systemic disorders.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
46. Course Syllabus, “Update on colon cancer.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
47. Course Syllabus, “Diagnosis and differential diagnosis of cystic pancreatic tumors.” Harvard Medical School Gastrointestinal, Liver, and Pancreatic Pathology Course, Boston, MA, May 4-7, 2009.
Thesis
Lauwers GY. “Esophageal Ectopic Gastric Mucosa.” Paris, France- University of Paris [Paris VII - Didier Diderot] (Centre Hospitalier Universitaire Lariboisière - Saint Louis), 1986.
Abstracts (abstracts of published studies have been deleted)
1. Fromont-Hankard G, Evana J, Lauwers GY, Masood S. Transforming Growth Factor b Expression in Normal Human and Celiac Disease Small Intestinal Biopsies. Gastroenterology 1995, 108:A967.
2. Broome TA, Bergeron RJ, Lauwers GY, Sninsky CA. Diethylhomospermine, A Synthetic Polyamine Analog, Reduces the Extent of Acetic Acid-Induced Colonic Mucosal Damage in Rats. Gastroenterology 1995, 108:A788.
3. Lauwers GY, Fujita S, Wada Y, Scott G, Ostoshi M. Mucosal histologic changes associated with early adenocarcinoma of the proximal stomach in Japan. Mod Pathol 1996; 9:60A.
4. Dickson RC, Lauwers GY, Rosen CR, Cantwell R, Nelson DR, Lau JYN. Serum Alpha Glutathlone S-Transferase (a-GST) as a Predictor of Early Allograft Rejection in Liver Transplant Recipients. Hepatology 1997; 26:501A.
5. Furman J, Lauwers GY, Shimizu M. Gland Neck Dysplasia in Diffuse Gastric Cancer: a Morphometric Study. Mod Pathol 1998; 11:64A.
6. Mishra G, Lauwers GY, Lind S, Lynch J, Braylan R. Endoscopic ultrasound (EUS): An underutilized tool in the management of malt lymphoma. Gastrointest Endosc 1999;49:607.
7. Mishra, G., Lauwers GY, Lind, S., Lynch, J., and Braylan, R. Gastrointest Endosc 1999; 49, 607.
8. Nelson DR, Soldevila-Pico C, Lauwers GY, Abdelmalk M, Reed A, Hemming A, Van der Werf W, Howard R, Davis GL. The effect of anti-interleukin (IL)-2 receptor therapy on the course of hepatitis C recurrence after liver transplantation. Hepatology 2000;32:184.
9. Mishra G, Vogel S, Lauwers GY, Marsh R, Zlotecki R, Bhutani MS. Analysis of endoscopic appearance and a re-staging endoscopic ultrasound (EUS) after neoaduvant therapy in the management of esophageal cancer. Gastrointest Endosc 2000;51:7056.
10. Ormsby AH, Gramlich TL, Montgomery E, Bronner M, Greenson J, Haber M, Lamps L, Lauwers GY, Lazenby A, Lewin D, Robert M, Washington K, Hart J, Richter JE, Goldblum JR. Cytokeratin Subset (CK/20) Immunostaining in Biopsies of Barrett’s Esophagus and BE-Related Dysplasia/Adenocarcinoma: A Multi-Institutional Study. Mod Pathol 2000;13:85A.
11. Mishra, G., Vogel, S., Lauwers, GY, Marsh, R., Zlotecki, R., and Bhutani, M. S. Analysis of endoscopic appearance and a re-staging endoscopic ultrasound (EUS) after neo-adjuvant therapy in the management of esophageal cancer (EC). Gastrointest Endosc 2000;51:7056A.
12. Wang, H. L., Goldblum J., Lauwers, GY., Burgart, L., Lewin, D., Montgomery, E., Washington, K., Bronner, M., Xiao, S. Y., Greenson, J., Lamps, L., Lazenby, A., Hart, J. Biologic behavior and molecular pathology of colorectal neuroendocrine carcinomas. Mod Pathol 2001;14:98A
13. Bronner M, Emond M, Burgart L, Goldblum J, Greenson J, Haber M, Hart J, Lauwers GY, Lazenby A, Lewin D, Robert M, Washington K, Montgomery E. Diagnostic accuracy in ulcerative colitis. Mod Pathol 2002;15:513.
14. Batts KP, Burgart LJ, Goldblum JR, Greenson JK, Haber M, Lewin DN, Jain D, Lamps L, Lauwers GY, Montgomery E, Washington K. Sessile serrated colorectal polyp: a multi-institutional incidence study. Mod Pathol 2003;16:512.
15. Batts KP, Burgart LJ. Goldblum JR, Greenson JK, Haber M, Jain D, Lamps L, Lewin DN, Lauwers GY, Montgomery E, Washington K. Mixed hyperplastic/adenomatous colorectal polyps: a multi-institutional incidence study. Mod Pathol 2003;16:513.
16. Tang Z, Jing W, Deshpande V, Lauwers GY, Ferry J. Harris N, Zukerberg L. Lymphoid Lesions of the Colon: Analysis of Histologic Features. Mod Pathol 2003;16:610.
17. Graeme-Cook FM, Lauwers GY, Eatherton DE, Mino M. Immunophenotyping in Sinusoidal Elements in Hepatocellular Carcinogenesis. Mod Pathol 2003;16:1252.
18. Mino M, Varnholt H, Muzikansky A, Terris B, Batts KP, Yamabe H, Flejou JF, Cleary K, Vauthey JN, Lauwers GY. Influence of age on hepatocellular Carcinoma. Mod Pathol 2003;16:1282.
19. Richards CJ, McGrath D, Balis U, Fernandez-del Castillo C, Lauwers GY. Association and correlation of grade of pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous tumors (IPMT). Mod Pathol 2003;16:1297.
20. Mino M, Eatherton DE, Lauwers GY. Stump gastric cancers have different EBV status and mucin phenotype from conventional cancers but no distinct MSI status. Mod Pathol 2004; 17 Suppl 1:124A.
21. Mino M, Kirley SD, Claude K, Graeme-Cook FM, Lauwers GY, Zukerberg LR. Role of Cables, a cyclin-independent kinase (CDK) in interacting protein, in hepatocellular carcinogenesis. Mod Pathol 2004; 17 Suppl 1:307A.
22. Rahemtullah A, Mino M, Richards CJ, Lauwers GY. Intraductal papillary mucinous neoplasms (IPMNs): Past and present. Mod Pathol 2004; 17 Suppl 1:310A.
23. Varnholt H, Mino M, Terris B, Batts KP, Tanabe H, Lauwers GY. Liver fibrosis and clinicopathologic characteristics of hepatocellular carcinoma. Mod Pathol 2004;17 Suppl 1:313A.
24. Mino M, Kirley SD, Lauwers GY, Zukerberg LR. Mod Pathol 2005;18 Suppl 1:112A. Loss of Cables, a cyclin-dependent kinase (CDK) interacting protein, is frequent in intestinal type gastric dysplasia and early gastric cancer.
25. Ohana M, Mino-Kenudson M, Ban S, Puricelli W, Nishioka NS, Lauwers GY. Frequent persistence of dysplasia by systematic pathological evaluation after photodynamic therapy for Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma. Gastroenterology 2005;129:1109.
